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Mechanistic studies of Polycomb group proteins 
 
Abstract 
Most cells within multicellular organisms contain the same genetic information, yet the 
appropriate tissue-specific expression of genes is required for the proper formation of 
adult tissues. Genes can either be “turned on” or “turned off” from the initial zygotic state 
and maintained during subsequent cell divisions. Maintaining the correct expression 
profiles during cell divisions is accomplished by a number of different nuclear factors. 
One of the key families of proteins that maintains the repression of target genes during 
development is the Polycomb group (PcG) of proteins. PcG proteins form a number of 
different multi-subunit protein complexes that interact with specific regions of chromatin 
and direct the repression of nearby genes by reducing transcription. One PcG complex, 
Polycomb repressive complex 1 (PRC1), inhibits transcription and nucleosome 
remodeling as well as compacts chromatin, both in vivo and in vitro. The in vitro 
repressive activities map mainly to one subunit of Drosophila PRC1—the Posterior sex 
combs (PSC) protein. The PRC1 complex is conserved in many other organisms 
including mammals. To better understand the mechanisms involved in PcG mediated 
repression we undertook a biochemical structure/function analysis of mouse PRC1. In 
chapter one, I review the current understanding of PcG biology and a rationale for the 
dissertation is provided. In chapter two, data are presented that argues that a mouse PRC1 
protein, M33/Cbx2, which is non-homologous to PSC, is responsible for chromatin 
	   iv	  
compaction and repression of nucleosome remodeling. Data are presented that suggests 
these activities are localized to a basic, natively unfolded region of M33/Cbx2. In chapter 
three, we extend the findings from chapter two in an attempt to predict whether 
homologous PcG proteins from other species besides fly and mouse have biochemical 
activity. In agreement with predictions, a panel of recombinant PcG proteins was 
generated and data are presented that shows the predicted active PcG proteins are capable 
of both inhibition of nucleosome remodeling and compaction of chromatin. Finally, in 
chapter four, the implications of the data presented are discussed, and directions for 
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Chapter One: Introduction 
In higher eukaryotes, gene expression profiles must be established early in  
developing embryos and then be faithfully transmitted from progenitor cells through 
multiple cell divisions. The appropriate gene products are required to establish a 
particular tissue type; this is accomplished by either up-regulation or down-regulation of 
gene products. Proteins that up-regulate transcription are called activators, whereas 
proteins that down-regulate transcription are called repressors. Two key classes of protein 
complexes that accomplish this during development are the Polycomb group (PcG) and 
the Trithorax group (trxG). TrxG proteins are involved in gene activation whereas PcG 
proteins are involved in gene repression. One key function of trxG and PcG proteins is 
the maintenance of homeotic (Hox) gene expression patterns. It is now clear that trxG and 
PcG protein complexes function mainly by interacting with chromatin. Chromatin, at the 
most basic level, is the association of DNA and a core octamer of histone proteins. One 
way the cell modulates gene expression is by modifying the organization of chromatin to 
either promote or repress transcription. TrxG proteins have several enzymatic activities 
that modify chromatin and lead to gene activation whereas PcG proteins have both 
enzymatic and non-enzymatic activities that modify chromatin and lead to transcriptional 
repression. The rest of this introduction will focus on the biology of PcG protein function 
and the rationale for the experiments that are presented in chapters two and three. 
Drosophila Polycomb genetics 
 For over one hundred years Drosophila melanogaster has been used as a model 
organism for the study of biology. Given the speed at which flies reach adulthood, the 
ease of husbandry, relatively complicated body-plan, and evolutionarily conserved genes, 
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Drosophila makes an ideal model system for the study of development. Early 
development in Drosophila begins with anterior-posterior gradients of mRNAs and 
proteins that are maternally deposited (Figure 1.1A) (Driever and Nusslein-Volhard 
1988a; Driever and Nusslein-Volhard 1988b). These gradients establish the expression 
patterns of gap and paired-rule genes, collectively known as the segmentation genes. The 
segmentation gene products initiate the anterior-posterior expression patterns of the 
homeotic (Hox) genes in segments; these patterns are subsequently maintained 
throughout development (Akam 1987). In Drosophila, the Hox genes are localized in two 
different clusters: The Bithorax Complex (BX-C), a large (~315 kb) region that encodes 
three homeotic genes, and the Antennapedia Complex (ANT-C), which encodes five 
genes (Figure 1.1B) (Lewis 1978; Duncan 1987; Kaufman et al. 1990). The homeotic 
genes encode DNA-binding transcription factors that regulate the anterior-posterior 
development of Drosophila by activating target genes in only the proper segments of 
developing embryos. Missexpression of a Hox gene in segments where it is normally 
inactive leads to transformations of that segment to a fate that is more anterior or 
posterior. For example, mutations in one Hox gene, Sex combs reduced (Scr), lead to the 
loss of bristles (sex combs) that are normally found only on the front legs of adult male 
flies (Kaufman et al. 1990; Pattatucci et al. 1991). Ectopic expression of Scr leads to the 
formation of sex combs on the second and third sets of legs on male flies, a location 






Figure 1.1 Homeotic genes in Drosophila development 
A. Examples of patterning formation during drosophila embryonic development. Initial 
gradients are formed using maternally contributed mRNAs and proteins. These gradients 
initiate the patterns of the gap and paired-rule genes, which help to set up the initial 
boundaries of expression of the Homeotic (Hox) genes. Hox gene expression boundaries 
are subsequently maintained by the Polycomb and trithorax goup proteins. B. Genomic 
organization of the two Drosophila Hox clusters: Antennapedia Complex (ANT-C), and 
Bithorax Complex (BX-C). Colors correspond to boundaries of expression as depicted in 
panel A. Based on Figure 1 of Generating patterns from fields of cells (Sanson 2001). 
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The segmentation genes are only active early in development, yet the Hox genes 
expression patterns are maintained through adulthood. How might the expression patterns 
be maintained? In 1947, P. Lewis isolated a mutant fly with ectopic sex combs on the 
second and third sets of legs and named this mutant Polycomb (Pc) (Lewis 1947).  
Homozygous mutants of Pc are embryonic lethal. Later on it was noted by E.B. Lewis 
that the homozygous mutant embryos had segments that resembled those that were more 
posterior and hypothesized that the function of Pc is to repress Hox genes in trans (Lewis 
1978).  
Since the segmentation genes establish the initial patterns of Hox genes, and PcG 
genes are required for Hox gene silencing throughout the rest of development, the 
Polycomb group is considered to be involved in the maintenance, rather than 
establishment, of gene repression (Struhl and Akam 1985; Simon et al. 1992). Possible 
mechanisms for how Pc mediated gene silencing is maintained during cell division will 
be discussed below. 
 Since the initial isolation of the Pc mutant, numerous other mutants have been 
isolated with the extra sex combs phenotype (Muller and Verrijzer 2009). Genes with 
mutants that have either the extra sex combs phenotype or enhance the phenotype of Pc 
alleles make up the Polycomb group (PcG) (Jürgens 1985). Based on the number of 
deficiencies that do not complement PcG mutants, it has been estimated that there are 
approximately 40 PcG genes (Jürgens 1985). Currently, 27 different complementation 
groups have been isolated, and the genes that have been molecularly characterized 
encode for proteins that form multi-subunit complexes involved in gene silencing 
(Gaytan de Ayala Alonso et al. 2007). 
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Like Pc, homozygous loss-of-function mutations in the other PcG genes are 
embryonic lethal with posterior transformations of segment identity (Lewis 1978).   
Trans-heterozygotes of two or more PcG mutants are more severe than either of the 
heterozygotes alone, suggesting that the gene products function together (Sato et al. 
1983). The rest of this section will focus on the genetics of Pc, Posterior sex combs 
(Psc), and the corresponding genes that have been characterized in knockout mice (For 
sake of brevity I will only discuss Psc and not the functionally related paralog Su(z)2). 
Since the isolation of the original Pc mutant in 1947, at least 50 additional alleles 
have been described, of which ten have been molecularly characterized (Messmer et al. 
1992). These alleles all have the Pc mutant phenotype: embryonic lethal when 
homozygous and ectopic sex combs on the second and third legs when heterozygous. The 
PC protein is 390 amino acids and contains two conserved domains: a N-terminal 
chromodomain and a C-terminal C-box (Paro and Hogness 1991). The chromodomain is 
common domain found in chromatin interacting proteins and binds to methylated histone 
tails (Lachner et al. 2001). The C-box is a protein-protein interaction motif that is 
required for interactions with other PcG proteins that contain RING domains (Wang et al. 
2008). Most of the characterized lesions that disrupt Pc function occur in either the 
chromodomain or C-box (Franke et al. 1995). In immunohistochemistry experiments, 
mutations in the chromodomain disrupt normal binding to chromatin, whereas the C-box 
is dispensable for localization (Messmer et al. 1992). 
The first characterized Posterior sex combs mutant, Psc1, is embryonic lethal 
when homozygous and has head defects, as well as transformations of the head and 
thorax to abdominal structures (Jürgens 1985). In heterozygotes, extra sex combs are 
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sometimes observed. Psc encodes for a 1603 amino acid protein and also contains two 
conserved domains near the N-terminus of the protein: a C3HC4 zinc finger RING 
domain, and a helix-turn-helix-turn-helix (HTHTH) motif (Brunk et al. 1991).  As with 
Pc, a number of alleles have been characterized molecularly. In one study, an allelic 
series of Psc mutants that has both moderate (hopeful) and strong (hapless) phenotypes 
was sequenced and characterized biochemically (Wu and Howe 1995; King et al. 2005). 
Hapless alleles are those that are lethal when in trans to other hapless alleles, whereas 
hopeful alleles are viable in trans to other hopeful alleles.  
Most of the mutant alleles sequenced have stop codons introduced within the 
coding sequence that result in truncations of PSC from the C-teminus (King et al. 2005). 
In general, there is a good correlation between the extent of truncation and the severity of 
the phenotype. Additionally, the activity of mutant PSC proteins in biochemical assays 
correlates well with the severity of phenotype. Specifically, the larger C-terminal 
truncations are less active in assays that measure the ability of PcG proteins to inhibit 
remodeling and transcription in vitro—two activities that are thought to be biologically 
relevant for PcG function in vivo. This study highlights the importance of the extended 
C-terminus of PSC for both in vivo and in vitro function. However, in addition to the 
truncation mutants, there is a point mutant, Psce23 (C268Y), that does not behave in 
accordance to the rest of the allelic series. The Psce23 mutant encodes for a full-length 
protein with a single amino acid change in the second cysteine of the C3HC4 RING 
finger domain. This mutant is interesting because although it falls into the hapless group 
and is homozygous lethal, the recombinant protein is fully active in vitro. This suggests 
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that the C-terminal region of PSC is required for both in vitro and in vivo function, 
whereas the RING domain is required only for in vivo viability. 
Mouse Polycomb genetics 
In 1991 the Bmi-1 gene was identified as a proto-oncogene in transgenic mice 
over-expressing the myc gene (Haupt et al. 1991; van Lohuizen et al. 1991b). In these 
animals over-expression of myc eventually leads to tumors, however, infection with 
Molony murine leukemia virus greatly accelerates the formation of tumors. The 
integration locations of the virus were mapped and nearly half of the integrations were 
found near the Bmi-1 locus, leading to increased expression of Bmi-1. Later that same 
year the predicted protein sequences of Psc and Su(z)2 were reported and it was 
established that Bmi-1 is a homolog of these PcG genes (Brunk et al. 1991; van Lohuizen 
et al. 1991a). Since then, homologs for many of the Drosophila PcG genes have been 
isolated from mammalian tissues, and with current genomic information it is clear that 
mammals have homologs for most of the described fly genes. In contrast to flies, 
mammals generally have multiple paralogs of each fly PcG gene; I will briefly describe 
the phenotypes of the mouse knockouts for the homologs of Psc and Pc. 
Bmi-1 was the first mouse PcG that was targeted for deletion (van der Lugt et al. 
1994).  Bmi-1 null mutant mice survive through embryogenesis and die shortly after 
birth. Bmi-1-/- mice exhibit mild posterior transformations of the axial skeleton that 
correspond to anterior shifts of Hox gene expression. Additionally, Bmi-1-/- mice have 
neurological abnormalities that result in partial paralysis as well as defects in 
haematopoiesis and proliferation. Knockout of another Psc and Su(z)2 homolog, Mel-18, 
leads to similar transformations of the axial skeleton, and similar defects in 
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haematopoiesis (Akasaka et al. 1996). However, there are differences: Mel-18 null mice 
have intestinal defects. Bmi-1-/-;Mel-18-/- double knockouts exhibit a much more severe 
phenotype and die as early embryos, whereas mice null for one gene and heterozygous 
for the other have intermediate effects (Akasaka et al. 2001). These results suggest that 
there exists some redundancy between the two proteins. However, while Bmi-1 is an 
oncogene, Mel-18 has been reported to have tumor suppressor activity (Kanno et al. 
1995). This, along with the differences in the knockouts, suggests that although there are 
overlapping functions, there exists specialization for the functions of each protein. There 
are four additional PSC homologs in mice; knockouts have not yet been described. 
Mice have five homologs of fly Pc, of which two have been knocked out (Core et 
al. 1997; Forzati et al. 2012). M33/Cbx2 was the first mouse Pc homolog to be cloned 
(Pearce et al. 1992; Core et al. 1997; Forzati et al. 2012). M33 null knockout mice 
develop to term and within a few hours of birth half of the animals die, and within 4 
weeks post birth 90% of the animals die with growth defects. Like Bmi-1 and Mel-18 
mutants, M33-/- mice have defects in the axial skeleton due to derepression of Hox genes. 
In addition, the mutants have thymus and spleen defects with a pronounced decrease in 
the number of T cells. Cultured fibroblasts and splenocytes have proliferation defects. 
M33-/-;Bmi-1-/- double mutants enhance the posterior transformations of the axial 
skeleton due to a greater derepression of Hox genes (Bel et al. 1998). Another phenotype 
that was not initially reported is a male-to-female sex reversal in null mice (Katoh-Fukui 
et al. 1998). Genetically male, M33 null mice fail to form external genetalia and instead 
50% develop uteri, oviducts and ovaries. Of the rest of the animals, 25% had both testis 
and ovaries. The significance of this phenotype is manifested by a clinical case in which 
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an XY patient presented with male-to-female sex reversal (Biason-Lauber et al. 2009). 
Analysis of the patients Cbx2 gene indicated two polymorphisms that result in P98L and 
R443P substitutions. A molecular explanation for both the mouse and human sex-reversal 
phenotype may be the missexpression of the Y-chromosome gene Sry. In M33-/- mutant 
gonads Sry and Sox9 expression is affected, and the sex-reversal phenotype is rescued by 
forced expression of Sry and Sox9 (Katoh-Fukui et al. 2011).  
Collectively, the phenotypes of the mouse PcG knockouts demonstrate that the 
role of PcG proteins in Hox gene regulation has been conserved. The increased severity 
of phenotypes in double mutants demonstrates that dosage effects with PcG proteins 
occurs both in flies and in mammals. In addition to common phenotypes, each of the PcG 
knockouts develops unique abnormalities, suggesting that there is regulation of more than 
just the Hox clusters. Indeed, genome wide mapping of PcG binding in flies and mice 
demonstrates that PcG proteins are involved in the regulation of hundreds of genes in 
addition to those located at the Hox clusters (Boyer et al. 2006; Bracken et al. 2006; 
Schwartz et al. 2006). 
Polycomb complexes 
Based on observed genetic interactions in flies it was proposed that PcG proteins 
may exist in multimeric protein complexes (Jürgens 1985). Indeed, currently there are 
five PcG complexes that have been identified in Drosophila (Beisel and Paro 2011). In 
general, these protein complexes contain both enzymatic and architectural factors.  The 
five isolated PcG complexes are: dRing-associated factors (dRAF), Polycomb repressive 
deubiquitinase (PR-DUB), Pho repressive complex (PhoRC), Polycomb repressive 
complex 2 (PRC2), and PRC1 (See table 1.1 and Figure 1.2 for a comparison of these 
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complexes in flies and mammals) (Shao et al. 1999; Kuzmichev et al. 2002; Muller et al. 
2002; Klymenko et al. 2006; Lagarou et al. 2008; Scheuermann et al. 2010). Of these, 
homologous complexes have been characterized in mammals for all of them except for 
PhoRC, although homologous proteins exist.  
What is the protein composition and activities of these PcG complexes? The 
dRAF complex contains two canonical PcG proteins: dRING (also known as Sex combs 
extra (Sce)) and Posterior sex combs (PSC), as well as dRAF1/dKDM2, dRAF2, and 
mTor (Lagarou et al. 2008). dRING is an E3 ubiquitin ligase that stimulates the 
monoubiquitination of histone H2A at lysine 118 (H2AK118ub1), a mark that is 
associated with silent chromatin domains. dKDM2 is a lysine demethylase that removes 
the activating H3K36me2 mark. Additionally, dKDM2 seems to stimulate the ubiquitin 
ligase activity of dRING, thereby linking the removal of an activating mark with the 
deposition of a repressive mark. 
PR-DUB is a recently characterized complex that contains the proteins Additional 
sex combs (Asx) and Calypso, and catalyzes the removal of H2AK118ub1 (Scheuermann 
et al. 2010). This mark is associated with regions of the genome that are normally 
repressed (Wang et al. 2004; Cao et al. 2005). Paradoxically these two PcG complexes 
have opposing enzymatic functions, the implications will be discussed below. 
PhoRC contains the sequence-specific DNA-binding protein pleiohomeotic 


























Figure 1.2 Drosophila and mammalian core Polycomb complexes 
Ovals depict the subunits of the various Drosophila Polycomb core complexes except 
where specified. Text next to the ovals indicates the homologous mammalian Polycomb 









(Klymenko et al. 2006). Pho mediates the recruitment of the complex to Polycomb 
repressive elements (PREs) and dSfmbt binds to methylated histone H3 and leads to 
repression of HOX genes.PRC1 and PRC2 were the first PcG complexes to be isolated. In 
Drosophila, the core of PRC2 contains the subunits Extra sex combs (ESC), Enhancer of 
zeste (E(z)), Suppressor of zeste 12 (Su(z)12) and Nucleosome remodeling factor 55 
(NURF55) (Kuzmichev et al. 2002; Muller et al. 2002). The SET domain of E(z) 
catalyzes the di- and tri-methylation of histone H3 lysine 27 (H3K27me3), a repressive 
mark that will be discussed below. In mammals there also exists PRC2 complexes 
containing homologs of the core subunits found in Drosophila. Additionally, a number of 
accessory proteins have been found to interact with mammalian PRC2. Other subunits 
that are found associated with the mammalian complex are Phd-finger protein 1 (PHF1) 
and JARID2 (Sarma et al. 2008; Peng et al. 2009; Shen et al. 2009; Pasini et al. 2010). 
PHF1 has been implicated in enhancing the methyltransferase activity of PRC2. JARID2 
is a protein that is currently under a lot of scrutiny. JARID2 contains a catalytically dead 
demethylase, owing to mutations in the catalytic domain, and is required for recruitment 
of PRC2 to chromatin targets (Pasini et al. 2010). Currently it is unclear whether or not 
JARID2 enhances the methyltransferase activity of PRC2, however, it remains a protein 
of much interest (Peng et al. 2009; Shen et al. 2009).  
Structural work has implicated H3K27me3 as a binding substrate for the 
chromodomain of Polycomb (PC), a component of PRC1 (Fischle et al. 2003; Min et al. 
2003). PRC1 is a megadalton protein complex that is generally thought of as the PcG 
complex that is the driving force behind transcriptional repression. A functional core 
complex of PRC1, called Polycomb core complex (PCC), contains the proteins PC, 
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Polyhomeotic (PH), Posterior sex combs (PSC) and Sex combs extra (Sce/dRing) 
(Francis et al. 2001). Several non-enzymatic functions of PCC have been demonstrated in 
vitro. PCC can inhibit nucleosome remodeling by the SWI/SNF complex on reconstituted 
nucleosomal arrays (Francis et al. 2001). Additionally, PCC can inhibit transcription off 
of similar templates (King et al. 2002). Incubation of PCC with nucleosomal arrays leads 
to compaction of the nucleosomes from the canonical “beads on a string” morphology to 
more compact structures (Francis et al. 2004). Interestingly, the PSC subunit of PCC is 
able to confer all of these biochemical activities on its own. As mentioned above, 
recombinant PSC protein corresponding to genetically isolated alleles has in vitro activity 
that correlates with the phenotypic data, suggesting that the in vitro data is predictive of 
PSC function in vivo (King et al. 2005). 
  Mammalian PRC1 has also been purified from HeLa extracts, but less is known 
about the biochemical functions of mammalian PRC1 (Levine et al. 2002). A core 
complex from mouse, mPCC, inhibits remodeling in vitro (Lavigne et al. 2004). 
Histone post-translational modifications and Polycomb 
 Within the cell are a host of different enzymes that can covalently modify 
proteins. These modifications can have profound effects on the localization or activities 
of target proteins. Within the nucleus are enzymes that specifically modify nucleosomes 
to regulate transcriptional profiles (Suganuma and Workman 2011). The nucleosome 
exists as an octamer of core histones that is wrapped with 147 base pairs of DNA. The 
canonical nucleosome is composed of two dimers of histones H2A and H2B, and a 
tetramer of histones H3 and H4. Much of the histone octamer exists as a globular core 
that is surrounded by the aforementioned DNA, however, the N-terminal ‘tails’ of the 
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histones are outside of the core--as well as C-terminal regions of H2A and H2B--and are 
unstructured in solution. The histone tails and certain locations within the octamer core 
can be covalently modified by enzymes that acetylate, methylate, phoshorylate or 
ubiquitinate at specific amino acid residues. Additionally, enzymes that remove each 
these modifications have been characterized. It is well established that certain 
modifications correlate well with the transcriptional status of nearby genes. These 
modifications can affect transcriptional activity either by directly affecting chromatin 
structure and/or by recruitment of proteins. The precise mechanisms by which most of the 
various histone modifications direct transcriptional regulation remain unclear. Polycomb 
and Polycomb-like protein complexes can catalyze both the deposition or removal of 
histone tail modifications as well as interact specifically with modifications.  
PRC2 and histone methylation 
In the mammalian PRC2 complex, EZH2, and to a lesser extent the paralogous 
protein EZH1, catalyze the di- and tri-methylation of histone H3 lysine 27 
(H3K27me2/3) (Kuzmichev et al. 2002; Muller et al. 2002; Shen et al. 2008). This 
modification is associated with regions of the genome where transcription is repressed. 
Additionally, a non-enzymatic function of PRC2 may be to help maintain repressive 
chromatin domains by directly interacting with and compacting chromatin. Chromatin 
compaction is observed in vitro when EZH2 and EZH1 are incubated with chromatin 
substrates (Margueron et al. 2008). Recently it was demonstrated that PRC2 binds to the 
H3K27me3 mark and this binding helps to enhance the methyltransferase activity of 
PRC2, likely through an allosteric mechanism (Hansen et al. 2008). The authors propose 
 16 
a model where PRC2 binding to H3K27me3 acts a positive feedback loop to maintain 
methylation patterns after cell division.  
It has been hypothesized that the enzymatic activities of PcG proteins could 
potentially target non-histone substrates. Recently, He et al. demonstrated that PRC2 can 
specifically methylate the GATA4 transcription factor (He et al. 2012). This methylation 
reduces the protein activity by preventing activation by p300. It will be interesting to 
determine what other non-histone substrates are targeted by PRC2 and other PcG 
enzymes.  
 The function of EZH1 is currently under debate. EZH1 is found in a complex 
with similar subunits as PRC2 and has high homology to EZH2, suggesting that it may 
have redundant functions (Margueron et al. 2008; Shen et al. 2008). Consistent with this, 
EZH1 can compact chromatin in vitro and can inhibit transcription when recruited to a 
reporter. However, a recent report using ChIP-Seq against EZH1 in undifferentiated and 
myogenic cell populations demonstrated that in differentiated populations EZH1 was 
associated with H3K4me3, PolII phosphorylated at serine 2, and active transcription 
(Mousavi et al. 2011). Knockdown of EZH1 led to the reduction of transcription at target 
genes, while overexpression increased the transcription of target genes. These differences 
in experimental outcomes will require further experimentation to address. 
 Methylation of H3K27 has been proposed to contribute to the recruitment of 
PRC1 through direct interactions of the modified histone tail with chromodomain (Cbx) 
proteins in PRC1 (Fischle et al. 2003; Min et al. 2003). However, it remains unclear the 
extent that H3K27me3 directs recruitment, as not all PRC1-bound locations are 
associated with the H3K27me3 modification (Schwartz et al. 2006). This issue is 
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confounded by the fact that in mammals there exists five PcG Cbx proteins (Cbx2, 4, 6, 7 
and 8), and multiple paralogs of the other core subunits. Recently, two papers 
investigated the role of Cbx proteins in mouse stem cells during differentiation and came 
to similar conclusions. They found that in undifferentiated stem cells, the Cbx7 paralog is 
predominantly expressed and maintains pluripotency by repressing differentiation genes 
within the context of PRC1 (Morey et al. 2012; O'Loghlen et al. 2012). Cbx7 also 
mediates the repression of Cbx2, 4 and 8. Upon differentiation, the other Cbx proteins are 
up regulated, incorporated into PRC1 complexes, and inhibit both pluripotency genes and 
Cbx7. Therefore, multiple Cbx paralogs function in antagonistic roles at different times 
during differentiation. Detailed analysis of the paralogs of the other components of PRC1 
will be necessary to determine whether they use similar mechanisms. 
The role of ubiquitination is not entirely clear. Some genomic targets of PcG 
complexes containing Ring1B do not require the E3 ligase activity of Ring1B (Eskeland 
et al. 2010). Loss of Ring1B results in decompaction of Hoxb  and d, and is rescued by 
catalytically inactive Ring1B. While the H2AK119ub1 mark is generally associated with 
silent chromatin, it may not be required at all loci. Recently another PcG complex has 
been described that deubiquitinates H2A (PR-DUB) (Scheuermann et al. 2010). In the 
absence of the deubiquitinase, PcG targets are derepressed. In compound mutants for 
both the H2AK118 ubiquitinase and deubiquitinase (Sce and Calypso) the mutant 
phenotype is enhanced over either mutant alone (Gutierrez et al. 2012). Paradoxically the 
repression of target genes requires a balance of both ubiquitinase and deubiquitinase 
activity. The authors speculate that while mono-ubiquitation of H2A by Sce is required 
for repression of target genes, the deubiquitinase may be required either to keep the 
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global pool of ubiquitin at a level that is usable by Sce, or to remove ubiquitinated H2A 
from PcG targets that repress by other mechanisms.  
Mechanisms of transcriptional repression by PcG proteins 
The precise mechanistic details of PcG mediated repression remain undetermined. 
There are several issues to consider regarding the mechanisms of PcG repression: 1) How 
are PcG complexes recruited to target loci? 2) What do the PcG complexes do when they 
are at target loci? 3) How is the repression program transmitted through many cell 
divisions? I will attempt to address the current understanding of these currently 
unresolved questions.  
The first issue to consider is how PcG complexes are recruited to the appropriate 
targets during development. It has long been known that there are DNA elements 
proximal to the Hox genes that act as sites of PcG protein nucleation. These sites, called 
Polycomb repressive elements (PREs), are generally composed of several different 
elements of around a hundred base pairs, and are necessary and sufficient for PcG 
mediated silencing (Simon et al. 1993). It has been suggested that PcG proteins are 
recruited to PREs by the combination of multiple low-affinity interactions with DNA-
binding proteins. In support of this, PREs contain many binding sites for specific DNA-
binding proteins. The best-characterized binding sites in PREs are for Pleiohomeotic 
(PHO), GAGA factor (GAGA), and ZESTE (Muller and Kassis 2006). PHO, the 
Drosophila homolog of mammalian Yin Yang-1 (YY1), was the first PcG protein with 
specific DNA-binding to be characterized (Shi et al. 1991; Brown et al. 1998).  PHO 
binds to hundreds of different sites on polytene chromosomes and overlaps with PSC at 
about 65% of the locations (Brown et al. 2003). PHO can interact with and recruit a 
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PRC1 complex in vitro, likewise YY1 has been found associated with both PRC1 and 
PRC2 (Garcia et al. 1999; Satijn et al. 2001; Mohd-Sarip et al. 2005). Despite 
considerable effort, it remains unclear how the DNA-binding proteins may recruit PcG 
proteins to PREs. Few specific DNA-binding proteins have been found stably associated 
in PcG complexes. Whether this is due to low-affinity contacts that do not survive 
purification is unknown. Additionally, despite PcG binding to hundreds of loci in the 
mammalian genome, only one mammalian PRE has been described (Woo et al. 2010). 
Whether mammals use different methods of recruitment is unknown.  
The second issue to consider is the mechanisms PRC1 uses to repress 
transcription after it is recruited. Several different mechanisms of transcriptional 
repression by PcG proteins have been proposed: inhibiting the transcriptional machinery 
by preventing the binding of factors (steric hindrance), directly interacting with and 
inhibiting the transcriptional machinery, or indirectly inhibiting transcription by 
compacting chromatin (Lund and van Lohuizen 2004). Multiple TBP-associated factors 
(TAFs) have been found to co-purify with fly PRC1, arguing against a pure model of 
steric hindrance (Saurin et al. 2001). However, it is possible that the localization of PRC1 
at promoters is sufficient to prevent transcription by sterically preventing the binding of 
factors involved in elongation.  
One piece of evidence for direct inhibition of transcription comes from an 
experiment with a LacZ reporter driven by an inducible hsp26 promoter (Dellino et al. 
2004). When a PRE is included in cis to the promoter, PcG dependent silencing occurs. 
Silencing of this construct did not prevent the binding of general transcription factors. 
TBP and PolII were found to be bound at the promoter, but initiation was blocked. In 
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addition to possible mechanisms where PRC1 directly inhibits the transcription 
machinery, it is also possible that the creation of compacted chromatin structure could 
lead to transcriptional repression.     
Compaction of chromatin is another possible mechanism by which PRC1 could 
potentially silence genes. There are several pieces of evidence that suggest compaction 
may be a strategy that PRC1 employs. In vitro, proteins from both PRC1 and PRC2 can 
cause chromatin arrays to condense (Francis et al. 2004; Margueron et al. 2008). The 
Drosophila PRC1 proteins PSC and Su(z)2 compact chromatin in vitro as visualized by 
electron microscopy (EM), and regions of PSC that are required for compaction are also 
required in the fly to prevent homeotic phenotypes (Francis et al. 2004; King et al. 2005; 
Lo et al. 2009). Additionally, we demonstrate here in Chapters two and three that PRC1 
proteins from mice, frogs and fish are capable of compacting chromatin. While 
compaction per se may not prevent the binding of polymerase to promoters, it may block 
elongation or the activity of nucleosome remodeling enzymes. Remodeling enzymes such 
as those in the trxG are needed for efficient transcription from certain loci. PRC1 proteins 
inhibit remodeling in vitro, though it is not known whether this is a result of directly 
interacting with the nucleosome remodeler or whether it is an indirect result of chromatin 
compaction (Shao et al. 1999; Francis et al. 2001). Order of addition experiments suggest 
that for optimal inhibition, PRC1 proteins need to be preincubated with the chromatin 
substrate prior to addition of remodeler; addition of PRC1 components at the same time 
as remodeler leads to less efficient inhibition (Francis et al. 2001). This data argue against 
a model in which PRC1 directly inhibits nucleosome remodeling complexes. 
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In addition to in vitro experiments, there exists some evidence that PRC1 proteins 
condense chromatin within the nucleus. In a recent experiment using fluorescent in situ 
hybridization (FISH) probes, Eskeland et al demonstrated that loss of Ring1B—a PRC1 
protein—causes local decompaction of chromatin at Hoxb and d loci, coincident with an 
increase of Hoxb and d gene expression (Eskeland et al. 2010). Reintroduction of wild 
type Ring1B or catalytically inactive Ring1B leads to rescue. Hoxb and d gene repression 
is rescued by either construct, arguing that at these loci, compaction, but not the 
H2A119ub1 modification, is required for repression. In another study done in 
Drosophila, the genome wide accessibility to the M.SssI DNA methyltransferase was 
determined (Bell et al. 2010). Lower accessibility, later replication, and lower 
transcription were observed at H3K27me3 positive sites. Collectively, these studies 
suggest that chromatin compaction is one mechanism utilized by PcG proteins to silence 
genes. Precisely how PRC1 compacts chromatin at atomic resolution remains to be seen. 
The final question that I will address is how might PcG mediated repression be 
transmitted through multiple cell divisions.  Long-standing unknowns in PcG biology are 
the mechanisms used to pass the silent state of genes to daughter cells. The propagation 
of silencing has been proposed to involve the passage of modified histones to the newly 
replicated DNA. A recent study that analyzed the turnover kinetics of histones using 
metabolic labeling challenges this proposal. Drosophila S2 cells were metabolically 
labeled with a methionine deriviative that allows for ligation to biotin (Deal et al. 2010). 
This allowed the authors to purify recently deposited nucleosomes and infer kinetics at 
specific genomic locations based on the DNA sequences that co-purify with newly 
translated histones. Interestingly, the authors find that nucleosome turnover is quite rapid 
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(~1.5 hrs) at PSC and ZESTE binding sites, meaning that nucleosomes are turned over 
multiple times during the cell cycle. Regardless, these turnover rates are slower than 
those found at sites of active transcription (1 hr). It will be interesting determine whether 
the turnover kinetics are constant throughout the cell cycle or whether they slow before 
mitosis. If histone modifications do not transmit epigenetic information to daughter cells, 
then how might it occur? 
Another recent paper analyzes whether the core of PRC1 can remain bound to 
chromatin templates during replication. In vitro assays demonstrate that PCC can remain 
bound to nucleosomal templates through replication (Francis et al. 2009). Interestingly, 
some PCC gets transferred to the newly replicated DNA, suggesting a possible 
mechanism for epigenetic inheritance. Newly replicated DNA may retain some PcG 
complexes to maintain the silencing after mitosis.  
The different mechanisms discussed above need not be mutually exclusive. Given 
the large size and diversity of PcG complexes that exist, it seems likely that they use 
many different mechanisms for repression. Different mechanisms may be utilized at 
different locations or different tissues.  
Dissertation overview 
 In order to further elucidate PcG-mediated repression we decided to characterize 
the functions of the core of the mouse PRC1 complex. By analyzing the contributions of 
different subunits of mouse PRC1 to transcriptional repression we hope to gain a better 
understanding of the molecular details that contribute to repression. Since PSC is the 
main engine of repression in Drosophila PRC1, the obvious question to address is 
whether the mouse homolog, Bmi1, is capable of repressive activities. Intriguingly, Bmi1 
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lacks the extended C-terminal region that is required for in vitro and in vivo activity by 
PSC. 
 In chapter two, we explore the mouse PRC1 complex by employing a 
structure/function analysis to determine whether any of mouse PRC1 proteins is capable 
of repressive activities. Surprisingly, we find that a protein non-homologous to PSC is 
responsible for in vitro repressive activities—M33/Cbx2, a homolog of fly PC. Next, we 
localize the active region of M33/Cbx2 to a part of the protein that is enriched for basic 
residues and is apparently natively unfolded in solution.  
Since it is surprising that a different homolog in the mouse complex contains the 
repressive activity, and this activity appears to be dependent on charge characteristics, we 
wondered whether we could make predictions on the functional activity of PcG proteins 
from other species. In chapter three, a computational approach was used to make 
predictions about the activity of proteins homologous to PSC—the active fly 
component—or to M33/Cbx2, the active mouse component. The analysis suggests that 
sometime during evolution these activities were “swapped” between subunits of PRC1. 
The predictions were tested by cloning and expressing a panel of proteins from other 
species and testing whether they can inhibit remodeling and compact chromatin. Finally, 
in chapter four the implications of the results are discussed and avenues for future 






Chapter Two: Identification of M33 as a functional homolog of Posterior sex combs 
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Protein complexes from the Polycomb group (PcG) group are responsible for the 
heritable silencing of Hox genes during development. Multiple PcG complexes have been 
characterized. One PcG complex, PRC1, is thought of as the major “engine” of 
repression. In flies, one subunit from the PRC1 complex, PSC, can inhibit remodeling of 
nucleosomal arrays as well as compact nucleosomal arrays outside of the context of the 
complex. However, the precise molecular mechanisms that lead to these activities remain 
elusive. To further understand how PcG proteins function in general, we undertake a 
molecular dissection of the mouse core PRC1 complex and compare the functional 
activities to PSC. By comparing the functional activities of mouse PRC1 to PSC we hope 
to be able to make biologically relevant generalizations about how PRC1 is able to 
repress transcription. In this chapter, we demonstrate that a mouse protein, M33/Cbx2—
that is not homologous to PSC—is able to inhibit remodeling of nucleosomes. We 
demonstrate that none of the conserved domains of M33/Cbx2 are required for activity. 
Using truncated recombinant protein we identify a domain of the protein that is required 
for optimal activity. Using point mutants that disrupt the positive charge of this domain 
we demonstrate the importance of charge for optimal inhibition activity. Next we 
reconstitute core PRC1 complexes with charge mutants of M33/Cbx2 and demonstrate 
that the charge domain is required in the context of the complex. We provide evidence 
that this domain is natively unfolded in solution. Finally we provide electron microscopy 





M33 is a functional homolog of PSC 
The Drosophila Polycomb group protein PSC is able to block remodeling and to 
compact nucleosomes in vitro, activities that might directly contribute to PRC1 mediated 
repression (King et al. 2002; Francis et al. 2004). We hypothesized that if these activities 
are important to PRC1 function they would be conserved in mammalian PRC1.  To 
investigate this we used the mouse PRC1 core complex (mPCC). As in Drosophila, a 
PRC1 core complex of M33, Ring1A, and Bmi1 retains the majority of repression 
activity, so we chose to focus on these three subunits, termed here mPCC∆Ph (Francis et 
al. 2001; Lavigne et al. 2004). We began by expressing mPCC and individual subunits of 
the core complex (Figure 2.1.A) to determine which, if any, individual subunits had in 
vitro activity versus the core.  
 We characterized the activity of mPCC subunits and subcomplexes using a 
solution assay that we previously used to characterize PcG proteins. The restriction 
enzyme accessibility assay (REA) measures the ability of PcG proteins to antagonize 
nucleosome remodeling by the ATP-dependent remodeling complex hSWI/SNF (Kwon 
et al. 1994; Francis et al. 2001). Briefly, we assembled nucleosomes onto a 2.5 kB 
DNA/chromatin template (G5E4) (Figure 2.1.B) using salt dialysis (Utley et al. 1998). 
This DNA fragment contains ten 5S nucleosomal positioning sequences.  At the center of 
this fragment is space for two additional nucleosomes, for a total of twelve. With two 
nucleosomes positioned in the central part of G5E4, one of them occludes a unique HhaI 
restriction site and prevents cutting. Movement of this nucleosome, which is 




Figure 2.1 Purification of Drosophila and mouse PcG proteins 
A. Coomasie stained gel of PcG proteins purified from overexpression in Sf9 cells. 
B. Schematic representation of G5E4 nucleosomal array used in assays. 5S: 5S 
nucleosomal positioning sequence. HhaI: unique HhaI restriction sequence that is 
inaccessible when packaged around a histone octamer. 
 
 
the G5E4 DNA.  Pre-incubation of the arrays with PcG proteins prevents efficient 
remodeling of nucleosomes by the hSWI/SNF remodeling complex, and therefore  
inhibits cutting by HhaI.  By titrating in PRC1 proteins or complexes and measuring the 
amount of cut and uncut DNA we are able to quantify their inhibitory activity.  
As anticipated from previous studies, when we preincubate nucleosomal arrays 
with PSC or with a mouse core complex composed of Bmi1, Ring1A and M33 
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(mPCC∆Ph), we see a concentration dependent inhibition of remodeling (Figure 2.2). 
Note that this core complex does not contain the Polyhomeotic (Ph) protein. Drosophila 
core complexes with and without Ph have similar in vitro activities (Francis et al. 2001). 
The inhibition of remodeling activity that we observe with mPCC∆Ph was lower than 
what we had previously measured, which could reflect differences in the activities of 
protein preparations (Lavigne et al. 2004).  
To determine the subunits of mouse PRC1 responsible for inhibition of 
remodeling activity, we tested proteins individually using this protocol.  Surprisingly, we 
did not observe any appreciable inhibition of remodeling by Bmi1, the mouse homolog of 
the biochemically active PSC.  Likewise, Ring1A did not exhibit any activity.  However, 
M33, the mouse homolog of Drosophila PC, exhibited activity that was similar in 
efficiency to the core complex and to PSC (Figures 2.2.A and B).  We conclude that the 
most active subunit in mouse PCC∆Ph for inhibition of remodeling is the M33 protein.  
Inhibition seems to require the presence of nucleosomes, as preincubation of M33 
with naked DNA template prior to adding HhaI results in inhibition of cleavage that is 
two orders of magnitude less than when the DNA template is assembled into 
nucleosomes, suggesting that M33 is not directly interfering with the restriction enzyme 
(Figures 2.3A and B).  
Inhibition of remodeling reactions were performed at ionic concentrations of 60 
mM, which are optimal for hSWI/SNF activity (Figures 2.3.C and D). We do not observe  
significant differences in inhibition of remodeling activity by M33 up to ionic conditions 





          Figure 2.2 M33 is the functional subunit of mouse PCC 
A. Agarose gel of restriction enzyme accessibility (REA) assay. After reactions were 
completed, uncut and cut Cy5 end-labeled G5E4 DNA was separated on an agarose gel, 
scanned using a Typhoon phosphorimager and quantified using ImageQuant software 
(GE Healthcare). The slower-migrating band represents the DNA that was not cleaved by 
HhaI (uncut), while the faster-migrating band represents cut DNA (arrowhead indicates 
cut DNA). 
B. Graph of the data obtained by quantification of DNA bands in panel A. Graphs were 
created in Kaleidagraph software (Synergy) using a non-linear sigmoidal curve fit. Error 
bars represent the standard deviation of three technical replicates. Apparent inhibition of 
remodeling is calculated by the following equation: 
 
(%Uncut with PcG protein and hSWI/SNF  - %Uncut with hSWI/SNF)   X100 




These results led us to question the conservation of domain structure between 
Drosophila PRC1 and mammalian PRC1.  The Drosophila PC protein can inhibit 
remodeling of nucleosomal templates, but it is at least 5-fold less efficient than PSC, 
while the mouse homolog of PC (M33) is at least one order of magnitude better at 
inhibiting remodeling than the mouse homolog of PSC (Bmi1) (Figures 2.2.A and B; note 
that Bmi1 displays a low level of compaction activity when assessed by electron 
microscopy, see below).  We have previously located the inhibition of remodeling and 
compaction activities in PSC to its C-terminus, a region with no obvious primary 
sequence homology to any of the PcG proteins in the mammalian complex.  We therefore 
set out to complete a structure/function analysis of M33 to determine what features of 
M33 were required for activity, and how those features compared to PSC.  
None of the conserved features of M33 are required for in vitro activity 
To identify the domain of M33 required for inhibition of remodeling, we 
expressed and purified M33 and deletion variants in E. coli. By using a cleavable GST-
tag on the N-terminus and a FLAG-tag on the C-terminus we were able to obtain M33 
and variants that were more homogeneous than the proteins we have obtained using the 
baculovirus system (Figures 2.4A and B).  We constructed a series of N- and C-terminal 
truncation mutants, expressed and purified them, and tested their activity in the REA 
assay (Figure 2.5A). In agreement with the above results, full length M33 purified from 
E. coli has an inhibitory activity that is similar to M33 purified from Sf9 cells (compare 
Figure 2.5B to 2.2B).  
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Figure 2.3 (Continued) Inhibition of remodeling requires nucleosomes and optimal salt 
concentrations 
A. REA inhibition activity of M33 preincubated with G5E4 chromatin or naked G5E4 
DNA. B. Agarose gel used to generate graph in panel A. For calculating apparent 
inhibition of remodeling for naked G5E4 it was assumed that 100% of the DNA would be 
uncut in the absence of HhaI. C. Remodeling activity of hSWI/SNF in the presence of 
increasing ionic strength. D. Quantification of the results from panel C. E. Inhibition 
activity of M33 in the presence of increasing ionic strength. F. Quantification of the 










M33 does not share significant sequence alignment with PSC, but it contains 
several domains that are conserved in other chromatin binding proteins: a chromodomain 
(CHD), an AT-Hook (ATH), and a PC C-box (CBOX) (Figure 2.4A).  Another domain, 
termed here as homology-domain (HD, amino acids 252-266), is a motif that is conserved 




Figure 2.4 Purification of amino and carboxy-terminus truncation mutants of M33 
A. Diagram of M33 truncation mutants tested for biochemical activity. CHD: 
chromodomain, ATH: AT-Hook motif, HD: homology domain, Cbox: C-box motif. 






We first determined whether any known domains in M33 contributed to its 
inhibitory activity. Deletion of either the ATH or HD motifs did not result in any 
reduction in inhibition activity (data not shown).  The CHD and CBOX domains interact 
with nucleosomes, and additionally, the CBOX domain is required for repression activity 
in Drosophila embryos and in transient transfection assays, as well as for interactions 
with RING proteins (Muller 1995; Schoorlemmer et al. 1997; Breiling et al. 1999; Satijn 
and Otte 1999; Fischle et al. 2003; Min et al. 2003; Wang et al. 2008). Surprisingly, 
deletion of the CHD or CBOX domains did not abolish the inhibition activity (Figures 
2.5A, B and C).  
Since none of the conserved features of M33 are required for our in vitro activity, 
we wondered whether there might be a non-conserved motif that was responsible for the 
inhibition of remodeling activity. Thus we decided to create a series of N and C-terminal 
deletions.   
We cloned and expressed a series of truncation mutants of the M33 protein and 
tested them in the REA assay for inhibition activity (Figures 2.5A, B and C). We find that 
truncations of the C-terminus to amino acid 105 (M331-105) still retain some repression 
activity. In contrast, N-terminal deletions to amino acid 248 (M33249-519), completely 
abolishes activity. Since the M331-197 and M3362-519 constructs retain near wild type levels 
of activity—approximately threefold and twofold less, respectively, we conclude that an 

















Figure 2.5 (Continued) Inhibition of remodeling by M33 truncation mutants 
A. Agarose gel images of the products from the REA assay preincubated with various 
M33 truncation mutants as described in Figure 2.4A. Numbers represent the highest 
concentration of variant used in 2-fold dilution series as determined by the Bradford 
assay and densitometry of the Coomasie stained gel in Figure 2.4B. B. Graph of 
inhibition activity of selected M33 C-terminal truncation mutants. Data were analyzed as 











Positively charged residues are required for optimal activity in vitro 
We wondered what characteristics are shared between the regions of M33 and 
PSC that are required for inhibition of remodeling.  Examination of the amino acid 
composition of M33 revealed a bias towards lysines and arginines--the two most 
positively charged amino acids. The C-terminal region of PSC that is required for in vitro 
and in vivo activity also has an overrepresentation of arginines and lysines. The predicted 
overall charge of M33 and PSC is +32.5 and +82.1, respectively. This is in contrast to 
Bmi1, inactive in the REA assay, which has a predicted overall charge of +10.1.  
We wondered if we could observe any correlation between the predicted overall 
charge of the M33 variants and inhibition of remodeling activity. Indeed, if we plot the 
predicted charge of the truncation mutants versus the concentration required for fifty 
percent inhibition of remodeling, we obtain a linear relationship with R2 = 0.7 (Figure 
2.6A). These charged amino acids are spread throughout M33 and PSC, which is 
reminiscent of another class of repressive proteins: the linker histones (Hansen et al. 
2006). We hypothesized that these basic residues in M33 are important for binding to 
chromatin and therefore contribute to PcG mediated repression. To test this hypothesis 
we synthesized mutant variants of the M33 protein that perturb overall protein charge. 
We systematically mutated every other lysine or arginine in M331-486 to alanine, 
beginning with K132A and ending with K240A, termed here M331-486;1KR_A, for a total of 
















Figure 2.6 (Continued) Inhibition of remodeling by M33 requires a basic region 
A. Graph of predicted protein charge at pH 7.0 versus IC50 as determined using 
Kaleidagraph software and performing a linear fit. Red circles represent data from M33 
truncation mutants and blue circles represent data from M33 charge mutants. 
B. Schematic representation of the charge-mutant proteins that were tested. 
C. Coomasie stained gel of M33 charge mutants expressed and purified from E. coli. D. 
Agarose gel with REA reaction products from M33 charge mutants schematically 













purpose because we find that deletion of the C-terminal 33 amino acids of M33 enhances 
expression and purification with marginal affect on in vitro activity.  Additionally, we 
generated a construct that mutates every other arginine or lysine from R262A to R415A 
(M331-486;2KR_A), as well as combination of the two regions (M331-486;1KR_A2KR_A).  These 
constructs reduce the predicted overall charge of M33;1-486 at pH 7.0 from +32.5 to 
+19.3, +22.3, and +9.3, respectively.  Finally, we synthesized a construct in which every 
other aspartic or glutamic acid was mutated to alanine, from E156A to E399A, for a total 
of 7 mutated residues (M331-486;1DE_A2DE_A). This construct is expected to increase the 
predicted charge to +39.3.  If overall positive charge of these domains is important to 
function, these mutations are expected to reduce and enhance the in vitro activity of M33, 
respectively.  
We expressed and purified these proteins to a level similar to M331-486 (Figure 
2.6C).  When we tested these proteins for inhibition of remodeling activity, we find that 
M331-486;1DE_A2DE_A has inhibition activity similar to M331-486 (Figures 2.6D and E). 
Additionally, M331-486;2KR_A inhibits remodeling to a similar extent as M331-486. However, 
both M331-486;1KR_A and M331-486;1KR_A2KR_A reduce inhibition activity, approximately 3-
fold in the case of M331-486;1KR_A and 5-fold for M331-486;1KR_A2KR_A (Data for all of the 
charge mutants is depicted as blue circles in Figure 2.6A).  These results are consistent 
with the idea that the charged residues within the M331-486;1KR_A region are important for 
optimal repression activity and agree with the deletion analysis above that suggests that 
the region between amino acids 62 and 197 is required for optimal repression activity. 















and no loss of activity in the M331-486;2KR_A mutant, we conclude that there must be other 
criteria than simple overall protein charge contributing to inhibition activity of M33. 
Since PcG proteins typically function within complexes, we tested whether the 
results we obtained with M33 alone could be replicated in the context of the core 
complex. We coexpressed two full length M33 charge variants with Bmi1 and Ring1A in 
Sf9 cells and were able to purify both mutant complexes to a level similar to the wild type 
complex (Figure 2.7A).  In agreement with the results obtained with M33 variants alone, 
PCC∆Ph;M331DE_A2DE_A inhibited remodeling to a similar extent as the wild type core 
complex, whereas PCC∆Ph;M331KR_A2KR_A reduces activity by more than 4-fold (Figures 
2.7B and C). 
We wondered whether inhibition activity is a general characteristic of any basic 
protein. We cloned two mouse genes that contain charge characteristics similar to M33: 
MrpL2, a mitochondrial protein with predicted charge of +32.96 and CTF8, a nuclear 
protein with a predicted charge of +30.52. These non-PcG proteins are 7-10 fold less 
active than M33, suggesting that features beyond overall charge are involved in PcG 
protein activity (Figures 2.7D, E and F). 
To determine whether there are any conserved sequence motifs within the region 
mutated in the M331-486;1KR_A construct, we performed a sequence alignment with frog, 
zebrafish, and chicken Cbx2 proteins (Figure 2.8). We find that five of the mutated 
residues are conserved among all four species, raising the possibility that these amino 
acids are involved in nucleosome interactions.  While we cannot rule out the loss of 
activity is due to disruption of protein structure, these results are consistent with the idea 
that the intrinsic charge of PcG proteins is important for repression activity.  
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Figure 2.7 (Continued) Inhibition of remodeling activity of charge mutant PcG 
complexes and basic non-PcG proteins 
A. Coomasie stained gel of M33 charge mutants in the context of the core PRC1 
complex. Proteins were expressed and purified from Sf9 cells. B. Agarose gel with REA 
reaction products from mPCC complexes containing charge mutants of M33. C. Plot of 
the quantification from the REA done with the charge mutant complexes. D. Coomasie 
stained gel of the non-PcG basic proteins expressed and purified from E. coli. E. Agarose 
gel with REA reaction products containing non-PcG basic proteins. F. Plot of the 











Figure 2.8 Alignment of one of the regions of M33 where basic residues were mutated. 
Asterisks represent positions where arginines or lysines were mutated to alanine. The 
alignment was generated by ClustalW and Jalview. 
 
Given the high number of hydrophilic amino acids in M33, one possibility is that 
the charged region is “natively unfolded” or “intrinsically disordered” (Uversky and 
Dunker 2010). Natively unfolded regions occur in other chromatin architectural proteins, 
including the PcG proteins RYBP and GAGA factor, and have been proposed to play a 
role in the function of PSC and Su(z)2 (Agianian et al. 1999; Emmons et al. 2009; Lo et 
al. 2009; Neira et al. 2009).  The linker histone regions required for chromatin 
compaction are intrinsically disordered in solution. Genome-wide predictions of natively 
unfolded regions in proteins forecast a high percentage of transcriptional regulators as 
having some intrinsic disorder (Garza et al. 2009; Sandhu 2009). Consistent with this 
idea, Metadisorder, a program that uses several different disorder prediction algorithms, 
predicts that M33 is folded within the chromodomain and CBOX, while the central 
portion that contains the 1KR_A region is disordered (Figure 2.9A) (Kurowski and 
 46 
Bujnicki 2003). Additionally, the Far-UV CD spectra of M331-486 demonstrates that it has 
the characteristic spectra of a protein that contains intrinsic disorder, specifically, a 
minima of molar ellipticity at 200 nM (Figure 2.9B) (Kelly and Price 2000). 
Compaction of chromatin by M33 
These results suggest that in the mammalian PRC1 complex M33 has similar 
inhibition of remodeling activity to a non-homologous fly protein, PSC, and that this 
activity corresponds to a basic characteristics of M33. We wondered whether M33 has 
conserved the ability to compact nucleosomal arrays, an activity that also resides within 
PSC. To test this, we used electron microscopy to visualize the interaction of mouse PcG 
proteins with arrays.  
PSC can efficiently compact nucleosome arrays, as observed visually by electron 
microscopy (EM) and as quantified by measuring the end-to-end distance of arrays in the 
EM images (Francis et al. 2004).  We used this technique to examine whether M33 can 
compact chromatin in a manner like PSC.  EM images of PcG proteins preincubated with 
G5E4 arrays were acquired, and images of low quality were discarded in a double-blind 
manner. Nucleosomal arrays alone look like the canonical “beads on a string” 
conformation (Figure 2.10A). Preincubation with Bmi1 tends to reduce the overall array 
length, but does not appear to promote intranucleosomal interactions. M33, in contrast, 
promotes the formation of compact particles consisting of multiple nucleosomes. To 
quantify the ability of these proteins to compact arrays, a single-blind measurement of the 
end-to-end length of protein/array particles was performed.  Full length M33 creates 
compacted nucleosome structures as determined by a significant decrease in end-to-end  
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Figure 2.9 M33 and intrinsic disorder 
A. Metadisorder plot of predicted protein disorder of M33 with schematic representation 
of M33 above. Regions over the disorder tendency threshold of 0.5 are classified as 
disordered. Region 1 and 2 represent the locations were charged amino acids were 
mutated. B. Far-UV circular dichroism spectra of M33.  
 48 
length when compared to arrays incubated with no protein (Figure 2.10B, students’s T-
test, p-value <.0001).  Surprisingly, despite being inactive in the REA, Bmi1 is also able 
to measurably compact arrays. However, M33 is able to compact chromatin significantly 




Figure 2.10 Compaction of nucleosomal arrays by mouse PcG proteins 
A. Representative EM images of nucleosomal arrays incubated with the indicated PcG 
protein. B. Box-plot representation of the measured maximal diameter of nucleosomal 
array particles. Particle length is the diameter of the smallest circle that can entirely 
surround one nucleosomal array. The box represents the upper and lower quartile, and the 
line splitting the box represents the mode. The open circles represent outliers, and the 
asterisks indicate a p-value of < .0001 using Student’s t-test. No protein: n=72, Bmi1: 






Materials and Methods 
Protein expression 
Baculovirus expression was done essentially as described (Francis et al. 2001). 
Briefly, Sf9 cells were grown in Hyclone CCMIII media at 27°C with shaking. One liter 
of cells was infected with either individual viruses for the expression of single subunits, 
or coinfected with multiple viruses for the expression of protein complexes. After 40 hrs, 
cells were harvested by centrifugation and washed in PBS prior to making nuclear 
extracts (NEs) as described (Sif et al. 1998). For the purification of single PcG subunits, 
NEs were bound to M2 resin (Sigma cat# A2220) for 4 hours, then washed extensively 
with BC buffer: 20mM HEPES pH 7.9, 0.2mM EDTA, 20% glycerol, 1mM DTT, 10mM 
PMSF and protease inhibitor cocktail (Roche complete protease inhibitor tablets) 
containing 500mM KCl. The M2 beads were then washed with BC buffer containing 
higher concentrations of KCl, up to 2M, before eluting in BC buffer containing 500mM 
KCl and 0.4mg/ml flag peptide. Purification of PcG complexes was identical except that 
the bound protein was washed with BC buffer containing 300mM KCl. 
For expression of GST fusion proteins in E. coli, Rosetta pLysS cells were 
transformed with pGEX6P1 containing the cDNA of interest. A single colony was used 
to inoculate 5ml of LB containing 25µg/ml chloramphenicol and 50µg/ml ampicillin, and 
grown overnight. The following morning, 250µl of the overnight culture was used to 
inoculate 250ml of the auto-induction media ZYP-5052: 12g/L Bacto tryptone, 24g/L 
Bacto yeast extract, 25mM (NH4)2SO4, 50mM KH2PO4, 50mM Na2HPO4, 0.05% glucose, 
0.2% alpha-lactose, 0.5% glycerol, 1mM MgSO4, 25µg/ml chloramphenicol and 50µg/ml 
ampicillin (Studier 2005). Cultures were shaken at 37°C for 5 hrs, then grown overnight 
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at 18°C. The cultures were collected by centrifugation at 4,000 RPM in a Beckman J6 MI 
for 20 min. Cell pellets were resuspended in 40ml of lysis buffer: 50mM HEPES pH 7.5, 
0.5mM EDTA, 1.6M KCl, 20% glycerol, 0.5mM MgCl2, 0.05% NP40, 1mg/ml 
lysozyme, 1mM DTT and protease inhibitors. The cells were taken through three freeze 
thaw cycles, then sonicated to shear DNA before centrifugation at 25,000g for 20min to 
remove debris.  5% polyethylenimine (PEI) in 20mM HEPES pH 7.5 was added 
dropwise to the supernatant while stirring to a final concentration of 0.15%, and stirred an 
additional 30min. This step was omitted for GST-MrpL2. The precipitated nucleic acid 
was removed by centrifugation at 25,000g for 20min. Extracts were bound to glutathione 
sepharose beads for 2hrs before washing with BC buffer containing increasing salt as 
described above for M2 purifications. Proteins were either cleaved or eluted off of the 
resin. For cleavage of proteins, the resin was incubated overnight with 20units of HRV 
3C protease in 5ml of BC buffer with 500mM KCl. Proteins were eluted from glutathione 
sepharose by incubating in BC buffer containing 500mM KCl and 40mM reduced 
glutathione. Eluted proteins were purified over M2 resin as described above. Purified 
proteins were quantified using the Bradford assay, and then normalized relative to each 
other by the intensity of protein bands on an SDS-Page gel analyzed using ImageJ 
software. 
Restriction enzyme accessibility assays 
Nucleosome arrays were assembled using HeLa histones as previously described, 
except that Cy5-labeled G5E4 was used (Sif et al. 2001). Human SWI/SNF was purified 
from HeLa nuclear extracts as described (Sif et al. 1998). Reactions were carried out in 
20µl volume containing 12mM HEPES pH 7.9, 12% glycerol, 60mM KCl, 0.12mM 
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EDTA, 0.12µg/µl BSA, 2mM ATP, 1.25mM MgCl2, and 2nM of assembled 
nucleosomes. Dilutions of PcG proteins were incubated with the arrays for 30min at 30°C 
prior to the addition of 100ng of SWI/SNF and eight units of HhaI. Reactions were 
incubated at 30°C for one hour before the addition of 10µl of stop buffer: 1.5mg/ml 
Proteinase K, 70mM EDTA, 10mM Tris pH 7.7, 1% SDS and 0.1% orange G. Reactions 
were incubated for 30min at 55°C, then separated on a 1% agarose gel in 1X TAE buffer. 
DNA was visualized on a Typhoon scanner and quantified using Imagequant software. 
Apparent Inhibition of remodeling was determined by the following equation: ((%uncut 
with PcG and hSWI/SNF - %uncut with hSWI/SNF) / (%uncut without hSWI/SNF - 
%uncut with hSWI/SNF)) x 100, and plotted using kaleidagraph. Curves were generated 
using an equation for a sigmoidal fit. 
Electron microscopy 
Electron microscopy experiments were carried out essentially as described 
previously (Francis et al. 2004), with the following minor modifications.  Binding 
reactions were carried out in either 30 or 60mM KCl, and NP40 added to a final 
concentration of 0.001%.  All reactions were set up at molar ratios of 8 PcG proteins to 1 
nucleosome, based upon total protein concentration.  This ratio was selected based on 
electrophoretic mobility shift assays carried out under the same conditions as EM, which 







Chapter Three: Charge characteristics predicts activity of divergent PcG proteins 
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The results presented in chapter two collectively suggest that a positively charged 
domain is responsible for the ability of PRC1 proteins to inhibit nucleosome remodeling.  
In vitro, M33 appears to inhibit remodeling enzymes in a manner that is dose responsive 
to the overall charge of the protein, whereas PSC appears to be more complicated.  Two 
truncation mutants of PSC that disrupt overall charge to variable degrees do not directly 
correlate with inhibition activity. PSC1-909 contains half as much overall charge as PSC456-
1603 yet inhibits remodeling to a similar extent (Lo and Francis 2010). This suggests that 
while overall charge may predict the inhibition of remodeling activity of M33, it may not 
be a characteristic that can be used to make generalizations for all proteins. Indeed, two 
proteins that have high overall charge—MrpL2 and Ctf8—were not as active as M33 in 
inhibition assays.  
Since M33 and PSC are not sequence homologs, we hypothesized that these 
proteins evolved to become functional homologs. This hypothesis predicts that organisms 
that are more closely related to Drosophila will have PSC homologs that are active. 
Likewise, it predicts that organisms more related to the mouse will have M33 homologs 
that are classified as active. In chapter three, we test these predictions by using a 
computational approach to classify proteins and then test these predictions using 
functional assays.   
Results 
Evolution of PcG proteins suggests charge is a predictor for in vitro activity 
In order to make predictions about the in vitro activity of PRC1 proteins we first 
generated a list of homologous proteins from other organisms. Homologous M33/PC and 
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Bmi1/PSC proteins were identified by searching the UniProt database for conserved 
chromodomain (IPR000953) and RING (IPR001841) InterPro signatures (Hunter et al. 
2009; 2011). Identified proteins from this search were filtered to PcG-like proteins using 
additional regions of homology: the CBOX domain for M33/PC and the extended RING 
homology domain for Bmi1/PSC by using hmmsearch (Eddy 2009). 
  Using PSC and M33 as known active proteins, and Bmi1 as a known inactive 
protein, the PcG proteins were classified as active or non-active using k-means clustering 
(Cock et al. 2009). The clustering was based on overall protein charge and regional 
charge. Overall charge was calculated using Biopython and regional charge was 
calculated as the percentage of 75 amino acid windows with an isoelectric point (pI) 
greater than 10.2. Proteins of the active class contained a regional charge of at least ten 
percent and overall charge of at least +15. Additional classification parameters, such as 
protein interaction and domain distribution, were considered but excluded as non-
informative.  
The total number of chromodomain and RING domain proteins identified were 44 
and 59, respectively, from 13 species (Table 3.1). Of these proteins, 32 chromodomain 
proteins and 4 RING proteins are predicted to inhibit remodeling. We then used 18S 
ribosomal RNA (rRNA) sequences from these 13 species to generate a phylogenetic tree 
to show the evolutionary relationships of these organisms (Figure 3.1). Interestingly, 
when we did this we observe an evolutionary point where the predicted activity of RING-
containing PcG proteins and chromodomain-containing proteins diverged. In 
deuterostomes, the PcG proteins predicted to be active are all chromodomain-containing. 
In protostomes, only predicted active RING domain containing proteins are observed. 
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Notably, despite the expansion of RING proteins in deuterostomes, we could not observe 
any Bmi1/PSC homologs that the analysis predicts to be active. We used this list to test 
the accuracy of our predictions. 
To accomplish this, we expressed and purified six evolutionarily divergent 
chromodomain and RING containing PcG proteins and tested their activity in vitro. 
These proteins were from the species Xenopus laevis, Danio rerio, and Caenorhabditis 
elegans (Figures 3.2A and B).  Overall, we tested one predicted inactive RING protein: 
frog Pcgf2, one predicted inactive Cbx protein: zebrafish Cbx7, one predicted active 
RING protein: worm Mig-32, and three predicted active Cbx proteins: zebrafish Cbx8, 
frog Pc1, and Cbx6 (see Figure 3.2A for predicted charge).  
Proteins were chosen based on evolutionary divergence from either mouse or 
Drosophila, and the availability of cDNAs. When we tested the activity of these proteins 
using the REA assay we find that, as predicted, frog Pcgf2 and zebrafish Cbx7 do not 
inhibit remodeling activity (Figures 3.2C and D). Conversely, preincubation with arrays 
using worm Mig-32, frog Pc1 or Cbx6, or zebrafish Cbx8 leads to efficient inhibition of 
remodeling. We do not observe any effect from leaving the GST-tag on our proteins nor 
for GST alone (Figure 3.3). Thus, for these proteins, regional charge was an accurate 









































Figure 3.1 Analysis of evolutionary conservation of PcG function 
 Phylogenetic tree of species containing RING domain or Chromodomain proteins from 
UniProtKb protein database. The tree is based on alignments of 18S rRNA from each of 
the species. Number of predicted PcG proteins represents the number of each class of 
proteins that was found in the UniProtKb database. Number predicted to inhibit 
remodeling is the number of proteins from each class that is expected to have inhibition 
activity based on overall protein charge and regional charge. The scale bar represents 













Figure 3.2 Inhibition of remodeling activity of PcG proteins from other species 
A. Charge properties of PcG proteins selected for in vitro activity analysis. The accession 
numbers for the proteins are: Pcgf2: NP_001084738.1; Cbx7: NP_001017853.1; Mig-32: 
NP_502293.2; Cbx6: NP_001088074.1; Cbx8: AAI54356.1; Pc1: NP_001081900.1. 
B. Coomasie stained gel of PcG proteins expressed and purified from E. coli.  
C. Agarose gel of REA assay reaction products. 





Figure 3.3 GST does not impact inhibition of remodeling activity 
Inhibition of remodeling activity of GST-tagged or untagged Pc1 and GST alone. A ten-
fold molar excess of GST did not inhibit remodeling. 
 
Compaction of chromatin by divergent PcG proteins 
Our results above are consistent with the hypothesis that the domain primarily 
responsible for inhibition of remodeling in vitro resides on the PSC homolog in flies and 
worms and resides on the PC homolog in vertebrates.  This idea posits that one subunit of 
PRC1--either an M33/PC homolog or a Bmi1/PSC homolog--will contain a region (or 
regions) of high positive charge that is important to repression of remodeling and also for 
compaction.  As we had previously done with M33 and Bmi1, we tested whether the 
proteins from species other that fly and mouse are able to compact nucleosomal arrays 
using electron microscopy  
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We quantified the ability of the PcG proteins from divergent species to compact 
arrays. In agreement with the previous REA assay, neither GST-Pcgf2 nor Cbx7 
(predicted inactive) is able to significantly compact arrays (Figures 3.4A and B, p-values 
0.1 and 0.8 respectively). These reactions yield arrays that have extended conformations. 
However, the proteins that inhibit remodeling (GST-Mig32, GST-Cbx6, GST-Cbx8 and 
Pc1) are able to significantly compact arrays (p-value < .0001) (Figures 3.4A and B). As 
with M33, these proteins promote intranucleosomal interactions. 
Thus, we have predicted PcG protein activity based on regional charge and 
overall charge and have shown that the predictions appear to hold true. Proteins that we 
predict to be active both inhibit remodeling and compact nucleosomes in vitro. In 








Figure 3.4 Compaction of nucleosomal arrays by diverse PcG proteins 
A. Representative images of nucleosomal particles incubated with various PcG proteins 
from different species.  
B. Box-plots of images as described above. No protein: n=79, GST-Pcgf2: n=86, Cbx7: 






Materials and Methods 
 
Computational classification of PcG proteins 
The UniprotKb database was queried for proteins containing chromodomains 
(IPR000953) or RING domains (IPR001841). This list was filtered for PcG proteins 
using HMMER by keeping only those proteins containing a CBOX for chromodomain 
proteins or extended homology for RING proteins. The predicted charge and regional 
charge of known active and inactive PcG proteins (regional charge is defined as the 
percentage of sliding windows of 75 amino acids where the average pI is 10.2 or above) 
was used to cluster the unknown PcG proteins into either active or inactive classes using 
the k-means method. Proteins of the active class contained at least 10% regional charge 
and overall charge of 15 or greater. The reproducible Python scripts for this analysis are 
available: https://github.com/chapmanb/mgh_projects/tree/master/dg_PSC. 
The phylogenetic tree was generated by using ClustalW to create an alignment of 18S 
rRNAs, and then using the maximum-likelihood method. The tree was drawn using 
NJplot. 
Protein expression 
Same as in chapter two. 
Restriction enzyme assay 
Same as in chapter two. 
Electron microscopy 






Chapter Four: Discussion and conclusions 
Overview 
In chapter two we have shown that the predicted protein charge of a mouse PcG 
protein correlates with in vitro activity. We extended this observation in chapter three by 
making a computational prediction of PcG activity in a variety of species and 
demonstrated that we can predict activity based on charge characteristics.  These results 
support the hypothesis that one key function for PRC1 proteins is the ability to compact 
nucleosomal arrays and repress chromatin remodeling. The conservation of this basic, 
charged domain suggests it may be important to silencing by PRC1 family proteins.  
Roles of natively unfolded proteins 
Natively unfolded or intrinsically disordered proteins were first described in the 
late 1980s (Sigler 1988). These early descriptions were focused on the proteins that are 
involved in transcriptional activation. Notably, it was observed that the negatively 
charged amino acids of proteins required for optimal transcriptional activation did not 
need to be precisely ordered; Ma and Ptashne elegantly demonstrated that the critical 
parameter appeared to be amino acid composition (Ma and Ptashne 1987). We find that 
canonical transcription repressors, the PcG proteins, also appear to have regions of 
disorder, yet, in contrast to transcriptional activators, contain high concentrations of basic 
amino acids. It is tempting to speculate that these oppositely charged disordered regions 
play a “yin-yang” role in transcriptional regulation. It is possible that, in addition to the 
roles in nucleosome interaction described above, these positively charged transcription 
repressors could directly interact with and inhibit the negatively charged activation 
domains of the transcriptional machinery. 
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There are several proposed reasons why proteins would contain regions of 
disorder. Disordered regions could potentially adopt different conformations that allow 
interactions with multiple binding partners. This “hub” function is expected to be 
beneficial for regulatory proteins; a single protein could potentially regulate many 
different proteins in a context specific manner (Gunasekaran et al. 2003). There is also 
the “fly-casting” model, where an extended conformation could allow a protein to 
“sample” a larger amount of space, forming and breaking low affinity contacts until 
conformational change induces tighter binding (Shoemaker et al. 2000). This is expected 
to promote interactions of low affinity and high specificity. One computational predictor 
of protein disorder—charge—was found to also be predictive of PcG functional activity, 
suggesting that charged disordered regions could possibly play a general role in PcG 
mediated repression.  
Charged domains and PcG function 
What might be the biological role for PcG charged domains in the repression of 
transcription? They appear to be predictive for both inhibition of remodeling and 
compaction of chromatin in vitro. Here we propose a model for how the charged domains 
of PRC1 function: 1) PRC1 is recruited to target loci and presents the charged domain to 
linker and/or nucleosomal DNA (Figure 4.1A).  2) The charged domain initially interacts 
with a nucleosome and creates more interactions with other nucleosomes (Figure 4.1B).   
3) Finally, oligomerization occurs through Ph or other protein-protein interactions to 




Figure 4.1 A model for chromatin compaction by the mouse PRC1 core complex 
A. The mouse PRC1 core complex is recruited to target loci, potentially through a variety 
of mechanisms. DBP: DNA binding protein. B. The charged region of M33 (indicated by 
plus signs) interacts with nucleosomes to compact chromatin. C. Further protein-protein 
interactions from other proteins in the core PRC1 complex drive spreading of compacted 
chromatin. 
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The CBOX domain of M33 is not required for in vitro repression activities, yet 
this motif is conserved and required for the repression of template DNA in cell-based 
assays (Schoorlemmer et al. 1997). This domain is required for interactions with 
Ring1A/B and Bmi1, which in turn interact with Ph proteins (Alkema et al. 1997; 
Gunster et al. 1997; Hashimoto et al. 1998; Hemenway et al. 1998; Satijn and Otte 1999). 
Thus we imagine an initially transient nucleosome-nucleosome interaction mediated by 
charged domains facilitates the further stabilization of a repressed chromatin structure 
that is mediated by other PRC1 proteins. Studies analyzing the dynamics of 
Cbx/chromatin interactions in culture cell models observe both transiently and stably 
associated Cbx proteins, consistent with an initial unstable interaction followed by step(s) 
that promote stable associations (Ren et al. 2008). 
PcG protein evolution  
What might be the explanation for how the charged domain evolved to reside on 
an M33/PC homolog in mammals as opposed to a Bmi1/PSC homolog in flies? We can 
imagine at least four possible explanations: 1) An early common ancestor had both a 
M33/PC and Bmi1/PSC homolog that each contained a charged region; sometime during 
evolution the characteristic charge was lost from one or the other homolog.  2) The 
charged region initially resided on either an M33/PC homolog or a Bmi1/PSC homolog 
in the common ancestor, but was lost during evolution and subsequently gained on the 
other PcG homolog.  3) The charged region initially resided on either an M33/PC 
homolog or a Bmi1/PSC homolog in the common ancestor, was gained on the other 
before being lost.  4) A convergent evolutionary event occurred: neither the M33/PC nor 
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the Bmi1/PSC homolog in the common ancestor had a charged domain, but during 
evolution one homolog or the other evolved it. 
Resolution of the possibilities mentioned above will require a more extensive 
examination of potential PcG members across evolution than has been performed here.  
Our phylogenetic tree was not a comprehensive list of all deuterostomes and protostomes, 
so it is possible that there may be unexpected active homologs in other species.  
Additionally, protein sequences may have been incorrectly annotated in the database that 
we queried or missing from organisms with incomplete genomes.  One unclear example 
involves Su(z)2, a homolog of PSC that can inhibit remodeling in vitro.  Su(z)2 was 
found in both the predicted active and inactive lists, although the isoforms in the inactive 
list appear to be short fragments of the full length protein that may not exist in vivo.  
Regardless of a full examination of this issue, the data reported here are consistent with 
the hypothesis that there was evolutionary pressure to maintain a highly charged domain 
in a component of PRC1. One possibility is that across multiple species the core of PRC1 
will contain several conserved domains/motifs: two RING fingers, a chromodomain, a 
SAM domain and a disordered/charged domain--defining the basic functional unit of 
PRC1. 
Molecular nature of PcG/chromatin interactions 
We do not understand the precise molecular mechanisms behind PcG protein 
interactions with chromatin. The flexible charged domains might interact with linker 
DNA, with nucleosomal DNA, with the histones themselves, or a combination of these 
chromatin components. We found that two non-PcG proteins with predicted charges 
similar to M33 do not inhibit remodeling as well as M33. This suggests a mechanism that 
 71 
does not rely solely upon the amount of positive charge.  It is possible that function 
involves a specific spacing of the charged residues and/or juxtaposition of the charged 
surface with other functional domains. For example, the majority of the active proteins 
that we characterized also contain a chromodomain, a known histone-binding domain, 
opening up the possibility that both DNA and histone contacts are required for optimal 
PcG repressive activities. 
 Previous studies have shown that intrinsically disordered regions of proteins can 
become folded upon interacting with their substrate.  This gives us hope that eventually 
the molecular mechanisms of chromatin condensation by PcG proteins can be unraveled 
using structural approaches.  
Technical challenges overcome 
Perhaps the greatest challenge to overcome regarding the biochemical study of 
PcG proteins is preparing the proteins. This technical challenge can be further subdivided 
into two separate issues: the expression of proteins at high enough levels to allow 
purification, and the subsequent purification of those proteins. The baculovirus 
expression system has been used to express many proteins that otherwise cannot be 
expressed in bacterial systems. I initially began expressions for the M33/Cbx2 variants 
and the evolutionary proteins using the baculovirus system. Full length M33 often was 
poorly expressed, and affinity purifications led to low amounts of purified protein, (~100 
ug/L expressed) of relatively low quality (~30% pure via Coomassie stain). Subsequent 
attempts to further purify M33/Cbx2 using ion exchange chromatography and size 
exclusion chromatography resulted in further loss of protein.  
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Similar results were obtained when expressions of the PRC1 proteins from frog, fish, and 
worm were attempted.  
 To attempt to overcome the limitations that were being faced using the 
baculovirus system, I chose to optimize the expression of soluble PcG protein using 
E.coli as an expression host. In ideal cases, expression in bacterial systems can lead to 
many milligrams of protein being produced per liter of cells cultured. Initial attempts at 
expression gave low yields of soluble protein. The rapid induction of protein synthesis by 
IPTG induction can often lead to the formation of inclusion bodies—insoluble aggregates 
of recombinant protein. Two strategies that have been used to increase the expression of 
soluble protein in E. coli are growth at lower temperature and slower induction. To this 
end, cultures were grown in auto-inducing media (AIM) overnight at 18 °C.  
The phenomena of auto-induction in bacteria was observed by F.W. Studier when 
he observed the induction of protein expression in cultures approaching saturation in the 
absence of inducer (Studier 2005). He hypothesized that low levels of lactose in the 
media were responsible for inducing the T7lac promoter when the cultures were nearing 
saturation, and reasoned that it was a result of the mechanisms bacteria use to regulate the 
use of carbon sources. At low densities, bacteria preferentially use glucose and uptake of 
lactose is prevented (Meadow et al. 1990). When cultures approach saturation and the 
glucose in the media is used up, lactose uptake can occur and induction occurs more 
gently. 
 The use of AIM and lower temperatures provides three potential benefits to 
protein expression: lower temperature helps with protein folding, slower induction 
prevents shock to the cells, and growth to saturation allows theoretically higher yields of 
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protein per liter of culture. Indeed, when GST-M33 fusion protein was expressed using 
the AIM method, milligram quantities of protein were obtained. This solved one technical 
problem, however other problems remained. After elution from glutathione sepharose 
resin, there were quantitative amounts of degraded protein and significant nucleic acid 
contamination. To solve the issue of degradation, an additional affinity tag was included 
at the C-terminus of the open reading frame.  
Numerous chemicals and reagents have been used to remove nucleic acid 
contaminations from extracts. These fall into two classes: nucleases and precipitation 
reagents. Since purified proteins would be used in assays containing nucleic acid, 
nucleases were excluded. Polyethylenimine (PEI) is a cationic polymer that has been 
used to precipitate nucleic acids from protein extracts (Burgess 2009). Low 
concentrations (0.15%) of PEI added to extracts efficiently precipitated nucleic acids. In 
initial trials at low salt concentrations non-reversible precipitation of the recombinant 
protein occurred. This was overcome by increasing the salt concentration to 1.6 M. 
 Using these conditions I was able to routinely get approximately 90% pure protein 
at milligram quantities per liter. These techniques proved to be generally useful for the 
expression and purification of PcG proteins as the frog, fish, and worm proteins were also 
successfully expressed and purified using these techniques. 
Future directions 
 The analyses presented here demonstrate that chromatin compaction and 
inhibition of remodeling activities by PRC1 proteins have been conserved over at least 
five different organisms. These activities appear to depend on basic regions of the 
proteins that are predicted to be intrinsically disordered. Several experimental 
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methodologies can be taken to attempt to address the questions that remain: 1) What is 
the in vivo relevance of the charged domains of M33? 2) Do the intrinsically disordered 
regions of M33 become folded upon interacting with chromatin? 3) What are the precise 
molecular interactions between M33 and chromatin?  
 The studies presented in chapters two and three utilized in vitro assays to dissect 
the function of a mouse PcG protein. It will be important to follow up the observations 
using in vivo or cell culture systems. Since genetic knock-in experiments in murine 
systems are tedious, cell culture model systems should be a useful tool to determine 
whether the charged domain of M33 has biological relevance. Rescue experiments with 
wild type or mutant constructs followed with target gene analysis should allow the 
determination of biological relevance. 
 It is tempting to speculate that the apparently intrinsically disordered regions 
become ordered upon binding to chromatin, yet it is also possible that these domains 
would become ordered through interactions with other proteins in the PRC1 complex. 
PRC1 is on the order of megadaltons, so it remains possible that regions of M33 that we 
find important for observed in vitro activity are typically masked by other proteins. 
However, the similar results obtained from M33 alone or within in the core complex 
suggests that is not the case. Regardless, these issues warrant further consideration.  
 There are a number of different methods useful for characterizing intrinsically 
disordered proteins. Small-angle X-ray scattering (SAXS), nuclear magnetic resonance 
(NMR) and deuterium exchange followed by mass spectrometry (DXMS) have all been 
used to this end (Lippens et al. 2006; Kathuria et al. 2011; Keppel et al. 2011). SAXS and 
NMR both require relatively concentrated protein samples and NMR has a functional 
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limit on the size of the protein being analyzed. DXMS provides a means to assay the 
relative accessibility of the peptide backbone, requires only minimal amounts of protein, 
and can give information about regions of polypeptides that become less accessible 
(ordered) upon binding to substrate. Any of these techniques should provide valuable 
information regarding the inherent flexibility of PcG proteins, and with DXMS it should 
be possible to map complex protein-protein and protein-DNA interaction motifs. These 
techniques provide intermediate details regarding the biophysical characteristics of 
proteins in contrast with the low resolution of the experiments described in chapters two 
and three and the high resolution afforded by X-ray crystallography.  
 Perhaps the biggest challenge with the highest reward will be high-resolution 
structural determinations of PcG proteins bound to repressed chromatin. Structural 
determination of PcG repressed chromatin—or of full length PcG proteins themselves—
would provide insight into the molecular mechanisms at work during PcG mediated 
silencing. It could potentially demonstrate whether disordered domains in fact become 
folded upon interactions with substrate and whether basic patches make contacts with 
DNA or histones. A beautiful crystal structure of the BAH domain of Sir3 bound to a 
nucleosome provides evidence that these macromolecular structures can be determined, 
and that disordered loops can become ordered upon binding to nucleosomes (Armache et 
al. 2011). Recent work with M33 variants suggests that stable complexes can be formed 
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Polycomb group (PcG) proteins are required for the epigenetic maintenance of developmental genes in a silent
state. Proteins in the Polycomb-repressive complex 1 (PRC1) class of the PcG are conserved from flies to humans
and inhibit transcription. One hypothesis for PRC1 mechanism is that it compacts chromatin, based in part on
electron microscopy experiments demonstrating that Drosophila PRC1 compacts nucleosomal arrays. We show
that this function is conserved between Drosophila and mouse PRC1 complexes and requires a region with an
overrepresentation of basic amino acids. While the active region is found in the Posterior Sex Combs (PSC) subunit
in Drosophila, it is unexpectedly found in a different PRC1 subunit, a Polycomb homolog called M33, in mice. We
provide experimental support for the general importance of a charged region by predicting the compacting
capability of PcG proteins from species other than Drosophila and mice and by testing several of these proteins
using solution assays and microscopy. We infer that the ability of PcG proteins to compact chromatin in vitro can
be predicted by the presence of domains of high positive charge and that PRC1 components from a variety of
species conserve this highly charged region. This supports the hypothesis that compaction is a key aspect of PcG
function.
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The coordinated regulation of development requires
the faithful maintenance of gene expression programs
through multiple cell divisions. Two classes of proteins
that maintain the epigenetic inheritance of gene states
are the Polycomb group (PcG) and Trithorax group (TrxG)
proteins (Kennison 1995; Schuettengruber et al. 2007).
These proteins act in complexes that either repress or
activate gene transcription, respectively (Lewis 1978;
Ingham and Whittle 1980; Kennison and Tamkun 1988;
Kennison 1993). PcG protein complexes map to hundreds
of genomic loci, the most notable being the Hox clusters
(Boyer et al. 2006; Bracken et al. 2006; Lee et al. 2006;
Schwartz et al. 2006). These proteins form several differ-
ent complexes, of which the best characterized are Poly-
comb-repressive complex 1 (PRC1) and PRC2 (Shao et al.
1999; Czermin et al. 2002; Kuzmichev et al. 2002; Muller
et al. 2002). In current models of PcG-mediated repres-
sion, PRC2 is recruited to target loci, where it methylates
Lys 27 of histone H3 (H3K27me3) (Cao and Zhang 2004).
This histone modification acts as a binding site for the
PRC1 protein Polycomb (PC), although there are indica-
tions that other as-yet-uncharacterized mechanisms are
also involved in targeting PRC1action (Muller andVerrijzer
2009; Simon and Kingston 2009; Morey and Helin 2010).
Binding of PRC1 to target loci is believed to be central
to the establishment of transcriptional silencing that is
stable through cell divisions. The mechanisms via which
PRC1 establishes repression are an area of intense study.
PRC1 was first defined in Drosophila, where genetic
studies initially identified the PcG genes via the pheno-
type of extra sex combs on the hind legs of male flies
(Slifer 1942; Lewis 1947). There are multiple PRC1 family
complexes in mammals. Each has some combination of
four proteins, encoded by genes homologous to the
Drosophila genes Pc, Ph, Psc, and Sce (dRing) (Cao et al.
2005; Schwartz and Pirrotta 2008). Potential mechanisms
by which PRC1 family complexes silence genes include
ubiquitylating histone H2A to initiate a block to tran-
scription, directly inhibiting the transcriptional machin-
ery, and creating a compacted state in chromatin that is
4Corresponding author.
E-mail kingston@molbio.mgh.harvard.edu.
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.17288211.
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refractory to transcription. Here we explore chromatin
compaction by PRC1 and the domain within PRC1 re-
sponsible for compaction.
In this study, compaction is defined as the ability to
reduce the average distance of nucleosomes from each
other as compared with the typical ‘‘beads on a string’’
seen with electron microscopy (EM). In vitro, compaction
is thought to be directly related to the ability of PRC1 to
inhibit chromatin remodeling, as the ability of PRC1
proteins to perform these two functions is highly corre-
lated. This in vitro work extends to in vivo observations,
since the ability of the Drosophila Posterior Sex Combs
(PSC) protein to compact nucleosomal arrays correlates
with the phenotypes of a set of mutations in PSC (King
et al. 2005). In other work, PRC1 is suggested to stabilize
nucleosomal turnover rates and create compacted chroma-
tin domains large enough to be detectable by light micros-
copy in cells (Deal et al. 2010; Eskeland et al. 2010). These
studies indicate that compaction is likely to be a biolog-
ically relevant mechanism of silencing by PRC1 family
complexes.
If compaction is central to PRC1 function, then the
ability to compact nucleosomal arrays should be con-
served across organisms that contain PRC1. Here we
show that the protein that is primarily responsible for
compaction in mouse PRC1 is M33 (Cbx2), a homolog of
Drosophila PC (Pearce et al. 1992). This was surprising, as
PC is not a homolog of PSC or Su(z)2, the proteins
responsible for compaction in Drosophila PRC1 (Francis
et al. 2004; Lo et al. 2009). We performed a structure/
function analysis ofM33 and found that it andDrosophila
PSC share a region that is highly basic and predicted
to have a disordered secondary structure. Using protein
charge as a basis, we identified putative PRC1 compo-
nents in other organisms that are expected to compact
nucleosomes and showed that these are functional in both
inhibition of remodeling and compaction. These studies
define a region in PRC1 proteins that functions similarly
to the Drosophila protein PSC. We provide evidence sup-
porting the idea that during evolution this key aspect of
PRC1 function diverged onto distinct subunits. That this
region appears to be present across evolution is consistent
with it playing a key role in PRC1 function.
Results
M33 is a functional homolog of PSC
The Drosophila PcG protein PSC is able to block remod-
eling and compact nucleosomes in vitro, activities that
might directly contribute to PRC1-mediated repression
(King et al. 2002; Francis et al. 2004). We hypothesized
that if these activities are important to PRC1 function,
they would be conserved in mammalian PRC1. To in-
vestigate this, we used the mouse PRC1 core complex
(mPCC). As in Drosophila, a PRC1 core complex of M33,
Ring1A, and Bmi1 retains the majority of activity, so we
chose to focus on these three subunits (Francis et al. 2001;
Lavigne et al. 2004). We began by expressing mPCC and
individual subunits of the core complex (Fig. 1A) to
determine which, if any, individual subunits had in vitro
activity versus the core.
We characterized the activity of mPCC subunits and
subcomplexes using a solution assay that we previously
used to characterize PcG proteins. The restriction en-
Figure 1. Identification of M33 as a functional homolog of PSC.
(A) Coomasie-stained gel of PcG proteins purified from over-
expression in Sf9 cells. (B) Schematic representation of G5E4
nucleosomal array used in assays. (5S) 5S nucleosomal position-
ing sequence; (HhaI) unique HhaI restriction sequence that is
inaccessible when packaged around a histone octamer. (C)
Agarose gel of REA assay. After reactions were completed,
uncut and cut Cy5 end-labeled G5E4 DNA was separated on
an agarose gel, scanned using a Typhoon PhosphorImager and
quantified using ImageQuant software (GE Healthcare). The
slower-migrating band represents the DNA that was not cleaved
by HhaI (uncut), while the faster-migrating band represents cut
DNA (arrowhead indicates cut DNA). (D) Graph of the data
obtained by quantification of DNA bands in C. Graphs were
created in Kaleidagraph software (Synergy) using a nonlinear
sigmoidal curve fit. Error bars represent the standard deviation
of three technical replicates. Apparent inhibition of remodeling
was calculated by the following equation:
ð%uncut with PcG and hSWI=SNF%uncut with hSWI=SNFÞ
ð%uncut without hSWI=SNF%uncut with hSWI=SNFÞ 3100:
Charge-mediated chromatin compaction
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zyme accessibility (REA) assay measures the ability of
PcG proteins to antagonize nucleosome remodeling by
theATP-dependent remodeling complex hSWI/SNF (Kwon
et al. 1994; Francis et al. 2001). Briefly, we assembled
nucleosomes onto a 2.5-kb DNA/chromatin template
(G5E4) (Fig. 1B) using salt dialysis (Utley et al. 1998).
This DNA fragment contains 10 5S nucleosomal posi-
tioning sequences. At the center of this fragment is space
for two additional nucleosomes, for a total of 12. With
two nucleosomes positioned in the central part of G5E4,
one of them occludes a unique HhaI restriction site and
prevents cutting. Movement of this nucleosome, which is
accomplished efficiently by ATP-dependent nucleosome
remodeling, allows HhaI to cut the G5E4 DNA. Preincu-
bation of the arrays with PcG proteins prevents efficient
remodeling of nucleosomes by the hSWI/SNF remodeling
complex and therefore inhibits cutting by HhaI. By titrat-
ing in PRC1 proteins or complexes and measuring the
amount of cut and uncut DNA, we are able to quantify
their inhibitory activity.
As anticipated from previous studies, when we prein-
cubate nucleosomal arrays with PSC or with a mouse
core complex composed of Bmi1, Ring1A, and M33
(mPCC), we see a concentration-dependent inhibition of
remodeling (Fig. 1C,D). The inhibition of remodeling
activity that we observe with mPCC was lower than
what we previously measured, which could reflect differ-
ences in the activities of protein preparations (Lavigne
et al. 2004).
To determine the subunits of mouse PRC1 responsible
for inhibition of remodeling activity, we tested proteins
individually using this protocol. Surprisingly, we did not
observe any appreciable inhibition of remodeling by
Bmi1, the mouse homolog of the biochemically active
PSC. Likewise, Ring1A did not exhibit any activity.
However, M33, the mouse homolog of Drosophila PC,
exhibited activity that was similar in efficiency to the
core complex and to PSC (Fig. 1C,D). We conclude that
the most active subunit in mouse PCC for inhibition of
remodeling is the M33 protein.
Inhibition seems to require the presence of nucleo-
somes, as preincubation of M33 with naked DNA tem-
plate prior to adding HhaI results in inhibition of cleavage
that is two orders of magnitude less than when the DNA
template is assembled into nucleosomes, suggesting that
M33 is not directly interfering with the restriction
enzyme (Supplemental Fig. S1A,B).
Inhibition of remodeling reactions was performed at
ionic concentrations of 60 mM, which is optimal for
hSWI/SNF activity (Supplemental Fig. S1C,D). We do not
observe significant differences in inhibition of remodel-
ing activity by M33 up to ionic conditions of 175 mM
(Supplemental Fig. S1E,F).
These results led us to question the conservation of
domain structure between Drosophila PRC1 and mam-
malian PRC1. The Drosophila PC protein can inhibit
remodeling of nucleosomal templates, but is at least
fivefold less efficient than PSC, while themouse homolog
of PC (M33) is at least one order of magnitude better at
inhibiting remodeling than the mouse homolog of PSC
(Bmi1) (Fig. 1C,D) (note that Bmi1 displays a low level of
compaction activity when assessed by EM; see below).
We previously located the inhibition of remodeling and
compaction activities in PSC to its C terminus, a region
with no obvious primary sequence homology with any
of the PcG proteins in the mammalian complex. We
therefore set out to complete a structure/function anal-
ysis of M33 to determine what features of M33 were re-
quired for activity and how those features compared with
PSC.
None of the conserved features of M33 are required
for in vitro activity
To identify the domain of M33 required for inhibition of
remodeling, we expressed and purified M33 and deletion
variants in Escherichia coli. By using a cleavable GST tag
on the N terminus and a Flag tag on the C terminus, we
were able to obtain M33 and variants that were more
homogeneous than the proteins we obtained using the
baculovirus system (Supplemental Fig. S2A). We con-
structed a series of N-terminal and C-terminal truncation
mutants, expressed and purified them, and tested their
activity in the REA assay (Fig. 2A). In agreement with the
above results, full-length M33 purified from E. coli has an
inhibitory activity that is similar to M33 purified from
Sf9 cells (cf. Figs. 1D and 2B).
M33 does not share significant sequence alignment
with PSC, but contains several domains that are con-
served in other chromatin-binding proteins: a chromodo-
main (CHD), an AT-Hook (ATH), and a PC C-box (CBOX)
(Fig. 2A). Another domain, termed here as the homology
domain (HD; amino acids 252–266), is a motif that is
conserved in M33/Cbx2 homologs but is not found in
other Cbx proteins.
We first determined whether any known domains in
M33 contributed to its inhibitory activity. Deletion of
either the ATH or HD motifs did not result in any
reduction in inhibition activity (data not shown). The
CHD and CBOX domains interact with nucleosomes, and
additionally, the CBOX domain is required for repression
activity in Drosophila embryos and in transient trans-
fection assays, as well as for interactions with RING
proteins (Muller 1995; Schoorlemmer et al. 1997; Breiling
et al. 1999; Satijn and Otte 1999; Fischle et al. 2003; Min
et al. 2003; Wang et al. 2008). Surprisingly, deletion of the
CHD or CBOX domains did not abolish the inhibition
activity (Fig. 2B,C; Supplemental Fig. S2B).
Since none of the conserved features of M33 are re-
quired for our in vitro activity, we wondered whether
theremight be a nonconservedmotif that was responsible
for the inhibition of remodeling activity. Thus, we de-
cided to create a series of N-terminal and C-terminal
deletions.
We cloned and expressed a series of truncation mutants
of the M33 protein and tested them in the REA assay for
inhibition activity (Fig. 2B,C; Supplemental Fig. S2B). We
found that truncations of the C terminus to amino acid
105 (M331–105) still retain repression activity. In contrast,
N-terminal deletions to amino acid 248 (M33249–519),
Grau et al.
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completely abolishes activity. Since the M331–197 and
M3362–519 constructs retain near wild-type levels of
activity, we conclude that an N-terminal region between
amino acids 62 and 197 is required for optimal repression
activity.
Positively charged residues are required for optimal
activity in vitro
We wondered what characteristics are shared between
the regions of M33 and PSC that are required for in-
hibition of remodeling. Examination of the amino acid
composition of M33 revealed a bias toward lysines and
arginines—the two most positively charged amino acids.
The C-terminal region of PSC that is required for in vitro
and in vivo activity also has an overrepresentation of
arginines and lysines. The predicted overall charge of
M33 and PSC is +32.5 and +82.1, respectively. This is in
contrast to Bmi1, inactive in the REA assay, which has
a predicted overall charge of +10.1.
We wondered whether we could observe any correla-
tion between the predicted overall charge of the M33
variants and inhibition of remodeling activity. Indeed, if
we plot the predicted charge of the truncation mutants
versus the concentration required for 50% inhibition of
remodeling, we obtain a linear relationship with R2 = 0.7
(Fig. 3A). These charged amino acids are spread through-
out M33 and PSC, which is reminiscent of another class
of repressive proteins: the linker histones (Hansen et al.
2006).
We hypothesized that these basic residues in M33 are
important for binding to chromatin and therefore con-
tribute to PcG-mediated repression. To test this hypoth-
esis, we synthesized mutant variants of the M33 protein
that perturb overall protein charge. We systematically
mutated every other lysine or arginine in M331–486 to
alanine, beginning with K132A and ending with K240A,
termed here M331–486;1KR_A, for a total of 13 residues
mutated (Fig. 3B; Supplemental Fig. S3B,C). We used the
M331–486 construct for this purpose because we found
that deletion of the C-terminal 33 amino acids of M33
enhances expression and purification with marginal ef-
fect on in vitro activity. Additionally, we generated a
construct that mutates every other arginine or lysine
from R262A to R415A (M331–486;2KR_A), as well as a com-
bination of the two regions (M331–486;1KR_A2KR_A). These
constructs reduce the predicted overall charge ofM331–486
at pH 7.0 from +32.5 to +19.3, +22.3, and +9.3, respec-
tively. Finally, we synthesized a construct in which every
other aspartic or glutamic acid was mutated to alanine,
from E156A to E399A, for a total of seven mutated
residues (M331–486;1DE_A2DE_A). This construct is expected
to increase the predicted charge to +39.3. If overall positive
charge of these domains is important to function, these
mutations are expected to reduce and enhance the in
vitro activity of M33, respectively.
We expressed and purified these proteins to a level
similar to M331–486 (Fig. 3C). When we tested these
proteins for inhibition of remodeling activity, we found
that M331–486;1DE_A2DE_A has inhibition activity similar
to M331–486 (Fig. 3D; Supplemental Fig. S2C). Addition-
ally, M331–486;2KR_A inhibits remodeling to an extent
similar to M331–486. However, both M331–486;1KR_A and
M331–486;1KR_A2KR_A reduce inhibition activity, approxi-
mately threefold in the case of M331–486;1KR_A and five-
fold for M331–486;1KR_A2KR_A (data for all of the charge
mutants are depicted as blue circles in Fig. 3A). These
results are consistent with the idea that the charged
residues within the M331–486;1KR_A region are important
for optimal repression activity and agree with the de-
letion analysis above that suggests that the region be-
tween amino acids 62 and 197 is required for optimal
repression activity. However, since there was no en-
hancement of activity in the M331–486;1DE_A2DE_A variant
and no loss of activity in the M331–486;2KR_A mutant, we
conclude that there must be criteria other than simple
overall protein charge contributing to inhibition activity
of M33.
Since PcG proteins typically function within com-
plexes, we tested whether the results we obtained with
Figure 2. Structure/function analysis of M33-mediated repres-
sion. (A) Diagram of M33 truncation mutants tested for bio-
chemical activity. (B) Graph of inhibition activity of selected
M33 C-terminal truncation mutants. Data were analyzed as
in Figure 1. (C) Graph of inhibition activity of selected M33
N-terminal truncation mutants.
Charge-mediated chromatin compaction
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M33 alone could be replicated in the context of the core
complex. We coexpressed two full-length M33 charge
variants with Bmi1 and Ring1A in Sf9 cells and were able
to purify both mutant complexes to a level similar to the
wild-type complex (Fig. 3E). In agreement with the results
obtainedwithM33 variants alone, PCCDPh;M331DE_A2DE_A
inhibited remodeling to an extent similar to the wild-type
core complex, whereas PCCDPh;M331KR_A2KR_A reduces
activity by more than fourfold (Fig. 3F; Supplemental Fig.
S2C).
We wondered whether inhibition activity is a general
characteristic of any basic protein. We cloned two mouse
genes that contain charge characteristics similar to M33
and expressed the proteins MrpL2, a mitochondrial protein
with predicted charge of +32.96, andCTF8, a nuclear protein
with a predicted charge of +30.52. These non-PcG proteins
are sevenfold to 10-fold less active thanM33, suggesting that
features beyond overall charge are involved in PcG protein
activity (Fig. 3G–I; Supplemental Fig. S2E).
To determine whether there are any conserved
sequence motifs within the region mutated in the
M331–486;1KR_A construct, we performed a sequence align-
ment with frog, zebrafish, and chicken Cbx2 proteins
(Supplemental Fig. S3A).We found that five of themutated
residues are conserved among all four species, raising the
possibility that these amino acids are involved in nucle-
osome interactions. While we cannot rule out that the
loss of activity is due to disruption of protein structure,
these results are consistent with the idea that the in-
trinsic charge of PcG proteins is important for repression
activity.
Given the high number of hydrophilic amino acids in
M33, one possibility is that the charged region is ‘‘na-
tively unfolded’’ or ‘‘intrinsically disordered’’ (Uversky
Figure 3. The role of charge in M33-mediated repres-
sion activity. (A) Graph of predicted protein charge at
pH 7.0 versus IC50 as determined using Kaleidagraph
software and performing a linear fit. Red circles repre-
sent data from M33 truncation mutants, and blue
circles represent data from M33 charge mutants. (B)
Schematic representation of the charge mutant pro-
teins that were tested. (C) Coomasie-stained gel of M33
charge mutants expressed and purified from E. coli. (D)
Plot of the quantification from the REA done with M33
charge mutants. (E) Coomasie-stained gel of M33
charge mutants in the context of the core PRC1
complex. Proteins were expressed and purified from
Sf9 cells. (F) Plot of the quantification from the REA
done with the charge mutant complexes. (G) Charge
characteristics of the non-PcG basic proteins cloned.
The accession numbers for the proteins are MrpL2,
NP_079578.1; and CTF8, AAH23107.1. (H) Coomasie-
stained gel of the non-PcG basic proteins expressed and
purified from E. coli. (I) Plot of the quantification from
the REA done with the non-PcG basic proteins.
Grau et al.
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and Dunker 2010). Natively unfolded regions occur in
other chromatin architectural proteins, including the
PcG proteins RYBP and GAGA factor, and have been
proposed to play a role in the function of PSC and Su(z)2
(Agianian et al. 1999; Emmons et al. 2009; Lo et al. 2009;
Neira et al. 2009). The linker histone regions required for
chromatin compaction are intrinsically disordered in
solution. Genome-wide predictions of natively unfolded
regions in proteins forecast a high percentage of tran-
scriptional regulators as having some intrinsic disorder
(Garza et al. 2009; Sandhu 2009). Consistent with this
idea, Metadisorder, a program that uses several different
disorder prediction algorithms, predicts that M33 is folded
within the CHD and CBOX, while the central portion that
contains the 1KR_A region is disordered (Supplemental
Fig. S4A; Kurowski and Bujnicki 2003). Additionally, the
far-UV circular dichroism (CD) spectra of M331-486 dem-
onstrate that it has the characteristic spectra of a protein
that contains intrinsic disorder; specifically, a minima of
molar ellipticity at 200 nM (Supplemental Fig. S4B).
Evolution of PcG proteins suggests charge is a predictor
for in vitro activity
The above studies collectively suggest that a positively
charged domain is responsible for the ability of PRC1
proteins to inhibit nucleosome remodeling. In vitro, M33
appears to inhibit remodeling enzymes in a manner that
is dose-responsive to the overall charge of the protein,
whereas PSC appears to be more complicated. Two trun-
cation mutants of PSC that disrupt overall charge to
variable degrees do not directly correlate with inhibition
activity. PSC1–909 contains half as much overall charge as
PSC456–1603, yet inhibits remodeling to a similar extent
(Lo and Francis 2010).
Since M33 and PSC are not sequence homologs, we
hypothesized that these proteins evolved to become
functional homologs. This hypothesis predicts that or-
ganisms that are more closely related to Drosophila will
have PSC homologs that are active. Likewise, it predicts
that organisms more related to mice will have M33
homologs that are classified as active. We sought to test
these predictions by using a computational approach.
Homologous M33/PC and Bmi1/PSC proteins were
identified by searching the UniProt database for con-
served CHD (IPR000953) and RING (IPR001841) InterPro
signatures (Hunter et al. 2009; The UniProt Consortium
2011). Identified proteins from this search were fil-
tered to PcG-like proteins using additional regions of
homology—the CBOX domain for M33/PC and the ex-
tended RING HD for Bmi1/PSC—by using hmmsearch
(Eddy 2009).
Using PSC andM33 as known active proteins and Bmi1
as a known inactive protein, the PcG proteins were
classified as active or nonactive using k-means clustering
(Cock et al. 2009). The clustering was based on overall
protein charge and regional charge. Overall charge was
calculated using Biopython, and regional charge was
calculated as the percentage of 75-amino-acid windows
with an isoelectric point (pI) >10.2. Proteins of the active
class contained a regional charge of at least 10% and
an overall charge of at least +15. Additional classifica-
tion parameters such as protein interaction and do-
main distribution were considered, but were excluded
as noninformative.
The total number of CHD and RING domain proteins
identified were 44 and 59, respectively, from 13 species
(Supplemental Table S1). Of these proteins, 32 CHD
proteins and four RING proteins are predicted to inhibit
remodeling. We then used 18S ribosomal RNA (rRNA)
sequences from these 13 species to generate a phyloge-
netic tree to show the evolutionary relationships of these
organisms (Fig. 4A). Interestingly, when we did this, we
observed an evolutionary point where the predicted
Figure 4. Analysis of evolutionary conservation of PcG func-
tion. (A) Phylogenetic tree of species containing RING domain
or CHD proteins from UniProtKb protein database. The tree is
based on alignments of 18S rRNA from each of the species.
Number of predicted PcG proteins represents the number of
each class of proteins that was found in the UniProtKb database.
Number predicted to inhibit remodeling is the number of
proteins from each class that is expected to have inhibition
activity based on overall protein charge and regional charge. The
bar represents 0.02 substitutions per site. (B) Charge properties
of PcG proteins selected for in vitro activity analysis. The
accession numbers for the proteins are Pcgf2, NP_001084738.1;
Cbx7, NP_001017853.1; Mig-32, NP_502293.2; Cbx6, NP_
001088074.1; Cbx8, AAI54356.1; and Pc1, NP_001081900.1. (C)
Coomasie-stained gel of PcG proteins expressed and purified from
E. coli. (D) Agarose gel of REA assay reaction products. (E) Plot of
the quantification of results obtained in D.
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activity of RING-containing PcG proteins and CHD-
containing proteins diverged. In deuterostomes, the PcG
proteins predicted to be active were all CHD-containing.
In protostomes, only predicted active RING domain-
containing proteins were observed. Notably, despite the
expansion of RING proteins in deuterostomes, we could
not observe any Bmi1/PSC homologs that the analysis
predicted to be active. We used this list to test the
accuracy of our predictions.
To accomplish this, we expressed and purified six
evolutionarily divergent CHD- and RING-containing
PcG proteins and tested their activity in vitro. These
proteins were from the species Xenopus laevis, Danio
rerio, and Caenorhabditis elegans (Fig. 4B,C). Overall, we
tested one predicted inactive RING protein (frog Pcgf2),
one predicted inactive Cbx protein (zebrafish Cbx7), one
predicted active RING protein (worm Mig-32), and three
predicted active Cbx proteins (zebrafish Cbx8, frog Pc1,
and Cbx6) (see Fig. 4B for predicted charge).
Proteins were chosen based on evolutionary divergence
from either mice or Drosophila, and the availability of
cDNAs. When we tested the activity of these proteins
using the REA assay, we found that, as predicted, frog
Pcgf2 and zebrafish Cbx7 do not inhibit remodeling
activity (Fig. 4D,E). Conversely, preincubation with ar-
rays using worm Mig-32, frog Pc1 or Cbx6, or zebrafish
Cbx8 leads to efficient inhibition of remodeling. We did
not observe any effect from leaving the GST tag on our
proteins or for GST alone (Supplemental Fig. S5). Thus,
for these proteins, regional charge was an accurate pre-
dictor of in vitro activity.
Compaction of chromatin by divergent PcG proteins
Our results above are consistent with the hypothesis that
the domain primarily responsible for inhibition of remod-
eling in vitro resides on the PSC homolog in flies and
worms and resides on the PC homolog in vertebrates.
This idea posits that one subunit of PRC1—either an
M33/PC homolog or a Bmi1/PSC homolog—will contain
a region (or regions) of high positive charge that is im-
portant to repression of remodeling and also for compac-
tion. To test whether these proteins are able to compact
nucleosomal arrays, we used EM to visualize the in-
teraction of PcG proteins with arrays.
PSC can efficiently compact nucleosome arrays, as
observed visually by EM and as quantified by measuring
the end-to-end distance of arrays in the EM images
(Francis et al. 2004). We used this technique to examine
M33 and the evolutionarily conserved PcG proteins to see
which of these proteins could compact chromatin in
a manner like PSC. EM images of PcG proteins preincu-
bated with G5E4 arrays were acquired, and images of low
quality were discarded in a double-blind manner. Nucle-
osomal arrays alone look like the canonical ‘‘beads on
a string’’ conformation (Fig. 5A). Preincubation with
Bmi1 tends to reduce the overall array length, but does
not appear to promote intranucleosomal interactions.
M33, in contrast, promotes the formation of compact
particles consisting of multiple nucleosomes.
To quantify the ability of these proteins to compact
arrays, a single-blindmeasurement of the end-to-end length
of protein/array particles was performed. Full-length M33
creates compacted nucleosome structures as determined
by a significant decrease in end-to-end length when com-
pared with arrays incubated with no protein (Students’s
t-test, P-value < 0.0001) (Fig. 5B). Surprisingly, despite being
inactive in the REA, Bmi1 is also able to measurably
compact arrays. However, M33 is able to compact chro-
matin significantly better than Bmi1 (P-value < 0.0001) .
Next we quantified the ability of the PcG proteins from
divergent species to compact arrays. In agreement with
the previous REA assay, neither GST-Pcgf2 nor Cbx7
(predicted inactive) is able to significantly compact arrays
(P-values = 0.1 and 0.8, respectively) (Fig. 6B). These reac-
tions yield arrays that have extended conformations. How-
ever, the proteins that inhibit remodeling (GST-Mig32,
GST-Cbx6, GST-Cbx8, and Pc1) are able to significantly
compact arrays (P-value < 0.0001) (Fig. 6B). As with M33,
these proteins promote intranucleosomal interactions.
Thus, we predicted PcG protein activity based on
regional charge and showed that the predictions appear
to hold true. Proteins that we predict to be active both
inhibit remodeling and compact nucleosomes in vitro. In
contrast, the predicted inactive proteins do not.
Discussion
Here we show that the predicted protein charge of
a mouse PcG protein correlates with in vitro activity.
100nm
No
Figure 5. Compaction of nucleosomal ar-
rays by mouse PcG proteins. (A) Represen-
tative EM images of nucleosomal arrays
incubated with the indicated PcG protein.
(B) Box plot representation of the measured
maximal diameter of nucleosomal array par-
ticles. Particle length is the diameter of the
smallest circle that can entirely surround one
nucleosomal array. The box represents the
upper and lower quartile, and the line splitting
the box represents the mode. The open circles
represent outliers, and the asterisks indicate
a P-value of <0.0001 using Student’s t-test. No
protein, n = 72; Bmi1, n = 50; M33, n = 30.
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We extended this observation bymaking a computational
prediction of PcG activity in a variety of species and
demonstrated that we can predict activity based on
charge characteristics. These results support the hypoth-
esis that one key function for PRC1 proteins is the ability
to compact nucleosomal arrays and repress chromatin
remodeling. The conservation of this basic, charged
domain suggests that it may be important to silencing
by PRC1 family proteins.
Roles of natively unfolded proteins
Natively unfolded or intrinsically disordered proteins
were first described in the late 1980s (Sigler 1988). These
early descriptions were focused on the proteins that are
involved in transcriptional activation. Notably, it was
observed that the negatively charged amino acids of pro-
teins required for optimal transcriptional activation did
not need to be precisely ordered; Ma and Ptashne (1987)
elegantly demonstrated that the critical parameter
appeared to be amino acid composition. We found that
canonical transcription repressors, the PcG proteins, also
appear to have regions of disorder, yet, in contrast to
transcriptional activators, contain high concentrations of
basic amino acids. It is tempting to speculate that these
oppositely charged disordered regions play a ‘‘yin-yang’’ role
in transcriptional regulation. It is possible that, in addition
to the roles in nucleosome interaction described above,
these positively charged transcription repressors could di-
rectly interact with and inhibit the negatively charged
activation domains of the transcriptional machinery.
There are several proposed reasons why proteins would
contain regions of disorder. Disordered regions could
potentially adopt different conformations that allow in-
teractions with multiple binding partners. This ‘‘hub’’
function is expected to be beneficial for regulatory pro-
teins; a single protein could potentially regulatemany dif-
ferent proteins in a context-specific manner (Gunasekaran
et al. 2003). There is also the ‘‘fly casting’’ model, where
an extended conformation could allow a protein to
‘‘sample’’ a larger amount of space, forming and breaking
low-affinity contacts until conformational change in-
duces tighter binding (Shoemaker et al. 2000). This is
expected to promote interactions of low affinity and
high specificity. One computational predictor of protein
disorder—charge—was found to also be predictive of
PcG functional activity, suggesting that charged disor-
dered regions could possibly play a general role in PcG-
mediated repression.
Charged domains and PcG function
What might be the biological role for PcG charged
domains in the repression of transcription? They appear
to be predictive for both inhibition of remodeling and
compaction of chromatin in vitro. Here we propose
a model for how the charged domains of PRC1 function:
(1) PRC1 is recruited to target loci and presents the
charged domain to linker and/or nucleosomal DNA
(Fig. 7A). (2) The charged domain initially interacts with
a nucleosome and creates more interactions with other
nucleosomes (Fig. 7B). (3) Finally, oligomerization occurs
through Ph or other protein–protein interactions to pro-
mote spreading or formation of higher-order chromatin
fibers (Fig. 7C).
The CBOX domain of M33 is not required for in vitro
repression activities, yet this motif is conserved and
required for the repression of template DNA in cell-based
assays (Schoorlemmer et al. 1997). This domain is re-
quired for interactions with Ring1A/B and Bmi1, which
in turn interact with Ph proteins (Alkema et al. 1997;
Figure 6. Compaction of nucleosomal arrays by diverse PcG
proteins. (A) Representative images of nucleosomal particles
incubated with various PcG proteins from different species. (B)
Box plots of images as described above. No protein, n = 79; GST-
Pcgf2, n = 86; Cbx7, n = 113; GST-Mig-32, n = 90; GST-Cbx6, n =
88; GST-Cbx8, n = 87; Pc1, n = 89.
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Gunster et al. 1997; Hashimoto et al. 1998; Hemenway
et al. 1998; Satijn and Otte 1999). Thus, we imagine that
an initially transient nucleosome–nucleosome interac-
tion mediated by charged domains facilitates the further
stabilization of a repressed chromatin structure that is
mediated by other PRC1 proteins. Studies analyzing the
dynamics of Cbx/chromatin interactions in culture cell
models observe both transiently and stably associated
Cbx proteins, consistent with an initial unstable interac-
tion followed by step(s) that promote stable associations
(Ren et al. 2008).
PcG protein evolution
What might be the explanation for how the charged
domain evolved to reside on an M33/PC homolog in
mammals as opposed to a Bmi1/PSC homolog in flies?We
can imagine at least four possible explanations: (1) An
early common ancestor had both an M33/PC and a Bmi1/
PSC homolog that each contained a charged region;
sometime during evolution, the characteristic charge
was lost from one or the other homolog. (2) The charged
region initially resided on either an M33/PC homolog or
a Bmi1/PSC homolog in the common ancestor, but was
lost during evolution and subsequently gained on the
other PcG homolog. (3) The charged region initially
resided on either an M33/PC homolog or a Bmi1/PSC
homolog in the common ancestor and was gained on the
other before being lost. (4) A convergent evolutionary
event occurred: Neither the M33/PC nor the Bmi1/PSC
homolog in the common ancestor had a charged domain,
but during evolution, one homolog or the other evolved it.
Resolution of the possibilities mentioned above will
require a more extensive examination of potential PcG
members across evolution than has been performed here.
Our phylogenetic tree was not a comprehensive list of
all deuterostomes and protostomes, so it is possible
that there may be unexpected active homologs in other
species. Additionally, protein sequences may have been
incorrectly annotated in the database that we queried or
missing from organisms with incomplete genomes. One
unclear example involves Su(z)2, a homolog of PSC that
can inhibit remodeling in vitro. Su(z)2 was found in both
the predicted active and inactive lists, although the iso-
forms in the inactive list appear to be short fragments of
the full-length protein that may not exist in vivo. Re-
gardless of a full examination of this issue, the data
reported here are consistent with the hypothesis that
there was evolutionary pressure to maintain a highly
charged domain in a component of PRC1. One possibility
is that across multiple species, the core of PRC1 will
contain several conserved domains/motifs—two RING
fingers, a CHD, a SAM domain, and a disordered/charged
domain—defining the basic functional unit of PRC1.
Molecular nature of PcG/chromatin interactions
We do not understand the precise molecular mechanisms
behind PcG protein interactions with chromatin. The
flexible charged domains might interact with linker
DNA, nucleosomal DNA, the histones themselves, or
a combination of these chromatin components. We found
that two non-PcG proteins with predicted charges similar
to M33 do not inhibit remodeling as well as M33. This
suggests a mechanism that does not rely solely on the
amount of positive charge. It is possible that function
involves a specific spacing of the charged residues and/or
juxtaposition of the charged surface with other functional
domains. For example, the majority of the active proteins
that we characterized also contain a CHD, a known
histone-binding domain, opening up the possibility that
both DNA and histone contacts are required for optimal
PcG-repressive activities.
Previous studies have shown that intrinsically disor-
dered regions of proteins can become folded upon inter-
acting with their substrate. This gives us hope that
eventually the molecular mechanisms of chromatin con-




Baculovirus expression was done essentially as described (Francis
et al. 2001). Briefly, Sf9 cells were grown in Hyclone CCMIII
medium at 27°C with shaking. One liter of cells was either
infected with individual viruses for the expression of single
subunits or coinfected with multiple viruses for the expression
of protein complexes. After 40 h, cells were harvested by
centrifugation and washed in PBS prior to making nuclear
extracts (NEs) as described (Sif et al. 1998). For the purification
of single PcG subunits, NEs were bound to M2 resin (Sigma,
catalog no. A2220) for 4 h, then washed extensively with BC
buffer (20 mM HEPES at pH 7.9, 0.2 mM EDTA, 20% glycerol, 1
mM DTT, 10 mM PMSF, protease inhibitor cocktail [Roche
Figure 7. Amodel for chromatin compaction by the mPCC. (A)
The mPCC is recruited to target loci, potentially through a
variety of mechanisms. (DBP) DNA-binding protein. (B) The
charged region of M33 (indicated by plus signs) interacts with
nucleosomes to compact chromatin. (C) Further protein–protein
interactions from other proteins in the core PRC1 complex drive
spreading of compacted chromatin.
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complete protease inhibitor tablets]) containing 500 mM KCl.
The M2 beads were then washed with BC buffer containing
higher concentrations of KCl, up to 2M, before eluting in BCbuffer
containing 500 mM KCl and 0.4 mg/mL Flag peptide. Purification
of PcG complexes was identical, except that the bound proteinwas
washed with BC buffer containing 300 mM KCl.
For expression of GST fusion proteins in E. coli, Rosetta pLysS
cells were transformed with pGEX6P1 containing the cDNA of
interest. A single colony was used to inoculate 5 mL of LB
containing 25 mg/mL chloramphenicol and 50 mg/mL ampicillin
and grown overnight. The following morning, 250 mL of the
overnight culture was used to inoculate 250 mL of the auto-
induction medium ZYP-5052 [12 g/L Bacto tryptone, 24 g/L
Bacto yeast extract, 25 mM (NH4)2SO4, 50 mM KH2PO4, 50 mM
Na2HPO4, 0.05% glucose, 0.2% a-lactose, 0.5% glycerol, 1 mM
MgSO4, 25 mg/mL chloramphenicol, 50 mg/mL ampicillin]
(Studier 2005). Cultures were shaken for 5 h at 37°C, then grown
overnight at 18°C. The cultures were collected by centrifugation
at 4000 rpm in a Beckman J6 MI for 20 min. Cell pellets were
resuspended in 40mL of lysis buffer (50mMHEPES at pH 7.5, 0.5
mM EDTA, 1.6 M KCl, 20% glycerol, 0.5 mM MgCl2, 0.05%
NP40, 1 mg/mL lysozyme, 1 mMDTT, protease inhibitors). The
cells were taken through three freeze–thaw cycles, then soni-
cated to shear DNA before centrifugation at 25,000g for 20 min
to remove debris. Five percent polyethelenimine (PEI) in 20 mM
HEPES (pH 7.5) was added dropwise to the supernatant while
stirring to a final concentration of 0.15%, and stirred an
additional 30 min. This step was omitted for GST-MrpL2. The
precipitated nucleic acid was removed by centrifugation at
25,000g for 20 min. Extracts were bound to glutathione sepharose
beads for 2 h before washing with BC buffer containing increas-
ing salt as described above for M2 purifications. Proteins were
either cleaved or eluted off of the resin. For cleavage of proteins,
the resin was incubated overnight with 20 U of HRV 3C protease
in 5 mL of BC buffer with 500 mM KCl. Proteins were eluted
from glutathione sepharose by incubating in BC buffer contain-
ing 500 mM KCl and 40 mM reduced glutathione. Eluted
proteins were purified over M2 resin as described above. Purified
proteins were quantified using the Bradford assay, and then nor-
malized relative to each other by the intensity of protein bands
on an SDS-PAGE gel analyzed using ImageJ software.
REA assays
Nucleosome arrays were assembled using HeLa histones as
previously described, except that Cy5-labeled G5E4 was used
(Sif et al. 2001). Human SWI/SNF was purified fromHeLa NEs as
described (Sif et al. 1998). Reactions were carried out in a 20-mL
volume containing 12mMHEPES (pH 7.9), 12% glycerol, 60mM
KCl, 0.12 mM EDTA, 0.12 mg/mL BSA, 2 mM ATP, 1.25 mM
MgCl2, and 2 nM assembled nucleosomes. Dilutions of PcG
proteins were incubated with the arrays for 30 min at 30°C prior
to the addition of 100 ng of SWI/SNF and 8 U of HhaI. Reactions
were incubated for 1 h at 30°C before the addition of 10mL of stop
buffer (1.5 mg/mL Proteinase K, 70mMEDTA, 10mMTris at pH
7.7, 1% SDS, 0.1% orange G). Reactions were incubated for 30
min at 55°C, then separated on a 1% agarose gel in 13 TAE
buffer. DNAwas visualized on a Typhoon scanner and quantified
using ImageQuant software. Apparent inhibition of remodeling
was determined by the equation
ð%uncut with PcG and hSWI=SNF%uncut with hSWI=SNFÞ
ð%uncut without hSWI=SNF%uncut with hSWI=SNFÞ 3 100
and plotted using Kaleidagraph. Curves were generated using an
equation for a sigmoidal fit.
Computational classification of PcG proteins
The UniprotKb database was queried for proteins containing
CHDs (IPR000953) or RING domains (IPR001841). This list was
filtered for PcG proteins using HMMER by keeping only those
proteins containing a CBOX for CHD proteins or extended
homology for RING proteins. The predicted charge and regional
charge of known active and inactive PcG proteins (regional
charge is defined as the percentage of sliding windows of 75
amino acids where the average pI is 10.2 or above) was used to
cluster the unknown PcG proteins into either active or inactive
classes using the k-means method. Proteins of the active class
contained at least 10% regional charge and overall charge of 15
or greater. The reproducible Python scripts for this analysis
are available (https://github.com/chapmanb/mgh_projects/tree/
master/dg_PSC).
The phylogenetic tree was generated by using ClustalW to
create an alignment of 18S rRNAs, and then using the maximum
likelihood method. The tree was drawn using NJplot.
EM
EM experiments were carried out essentially as described pre-
viously (Francis et al. 2004), with the following minor modifica-
tions. Binding reactions were carried out in either 30 or 60 mM
KCl, and NP40 added to a final concentration of 0.001%. All
reactions were set up at molar ratios of eight PcG proteins to one
nucleosome, based on total protein concentration. This ratio was
selected based on electrophoretic mobility shift assays carried out
under the same conditions as EM, which demonstrated binding of
M33 to nucleosomal arrayswithminimal aggregation at this ratio.
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Appendix B: Functional dissection of Polycomb repressive complex 1 reveals the    
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A key aspect of development is the ability to maintain
master regulatory genes in a repressed state when appro-
priate. Misexpression of even a single master regulatory
gene, such as those encoded in the HOX loci, can cause a
cell to behave in a manner incompatible with its body lo-
cation and tissue type. The most prominent set of factors
responsible for the maintenance of a repressed state at
master regulatory genes is called the Polycomb group
(PcG), after the founding gene in this family, Polycomb,
discovered in Drosophila in the late 1940s (Lewis 1947;
Lewis 1978). The PcG genes, which number roughly 16
depending on species, form several protein complexes that
are involved in repression. One of these complexes, Poly-
comb repressive complex 1 (PRC1), is believed to be the
central engine of repression.
The mechanisms via which the PcG system maintains
a repressed state faithfully throughout the lifetime of a cell
lineage are not fully understood. The system is targeted to
genes by specific loci called Polycomb response elements
(PREs). Several distinct DNA-binding factors bind to
PREs, localize PcG complexes via interactions with these
complexes, and allow these complexes to act at adjacent,
and many times distant (>50 kb), regions of the genome
(for review, see Ringrose and Paro 2007). More recently,
there have been some suggestions that noncoding RNAs
(ncRNAs) are also involved in targeting (Rinn et al. 2007;
Zhao et al. 2008). Once the targets are found, repression
involves methylation of lysine 27 of histone H3, ubiqui-
tylation of lysine 119 of histone H2A, binding to and sta-
bilization of nucleosome structure, and direct inhibition
of the transcription machinery (for review, see Simon and
Kingston 2009). Given the number of PcG components,
the variety of genes that are regulated, and the fact that
key targets such as the HOX clusters occupy ~500 kb in
the mammalian and in the Drosophila genomes, it seems
likely that a variety of mechanisms act in distinct combi-
nations on the various targets.
Several complexes are formed by PcG gene products.
In Drosophila, these include PRC1 (Shao et al. 1999; Sau-
rin et al. 2001), PRC2 (Czermin et al. 2002; Kuzmichev
et al. 2002; Müller et al. 2002), PhoRC (Klymenko et al.
2006), and PR-DUB (Scheuermann et al. 2010). PhoRC
binds to many PREs to help target the repressive PcG ma-
chinery; PRC2 methylates lysine 27 of histone H3 to help
target binding by the PRC1 complex, which creates a re-
pressive state on chromatin; and PR-DUB deubiquitylates
histone H2A, thus counteracting one of the functions of
the PRC1 family of complexes. The extent to which this
balance of counteracting PcG activities drives a repressive
state is not understood currently. It is also not clear
whether PRC2 is involved only in targeting PRC1 or
whether it directly represses gene expression in coordina-
tion with PRC1 as well.
PRC1 family members have been found in complexes
distinct from PRC1 as originally defined in Drosophila
(Table 1). These complexes also have tight interactions
with proteins that do not display a classic PcG phenotype
and thus are not bona fide PcG members. Complexes in
this family have several functions. Complexes that contain
the Bmi-1 and Ring1B proteins are able to ubiquitylate his-
tone H2A; the most active of these complexes also contain
the KDM2B protein or its homolog (Gearhart et al. 2006;
Lagarou et al. 2008). The role for ubiquitylation in direct-
ing repression is under investigation; it has been proposed
to impede transcriptional elongation (Stock et al. 2007) but
does not appear key for repression of HOX loci in mice
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(Eskeland et al. 2010). It is possible that the importance of
ubiquitylation varies according to the repressed target gene.
A second activity of the PRC1 family complexes, and a
focus of this chapter, is their ability to create a compacted
chromatin state that is refractory to ATP-dependent remod-
eling. Creation of a compacted state has been proposed to
direct repression by blocking steps in the transcription
process (Nakagawa et al. 2008), possibly at the level of
transcription initiation or transcription elongation. A sec-
ond focus of this chapter is the ability of auxiliary factors
to modulate activity and/or targeting of PRC1 activities.
To dissect the mechanism of PRC1 function, we have
analyzed domains of some of its central components. In
previous work, we showed that the Psc protein is respon-
sible for creating a compacted state of the template (Fran-
cis et al. 2001) and defined the regions of Psc responsible
for that activity (King et al. 2005). An issue that arose was
that there was no obvious homologous domain in mam-
malian Psc homologs: If this activity is central to PRC1
function, where might a domain reside that performs this
activity in mammals? In previous work, we had also
shown that a key protein involved in both activation and
repression in Drosophila, the Zeste protein, interacts di-
rectly with the core components of PRC1 (Saurin et al.
2001; Mulholland et al. 2003). This was perplexing be-
cause, although this protein is known to have roles in reg-
ulation in Drosophila, it has been shown to display
phenotypes consistent with the Trithorax group (Judd
1995), a set of genes isolated by their ability to suppress
PcG phenotypes. We have addressed the ability of Zeste
to dock with PRC1 and tested whether there are functional
outcomes from this interaction.
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Table 1. Selected PcG proteins
Drosophila Mouse Complex Domains Functional role(s)
Enhancer of zeste (E(sz)) Ezh1P PRC2 SET H3K27 Mouse
Ezh2 (KMT6, Enx-1) PRC2 SET
Suppressor zeste 12 (Su(z)12) Suz12 PRC2 Enhances Mtase activity of E(z)
Extra sex combs (Esc) Eed (lusk) PRC2 WD40 repeats Enhances Mtase activity of E(z)
Nucleosome remodeling Rbbp4 (Caf-1, mRbAp48) PRC2 WD40 repeats Nucleosome binding
factor 55 (Nurf55/Caf-1)
Polycomb-like (Pcl) Phf1 (Pcd1) Interacts PHD fingers and Recruitment, enhances Mtase
with PRC2 Tudor domain activity of PRC2
Mtf2 (Pcl2)
Phf19 (Pcl3)
Polycomb (Pc) Cbx2 (M33, MOD2, Pc1) PRC1 Chromodomain Binds H3K27triMe
AT-hook and 
Pc-box
Cbx4 (Pc2) PRC1 Chromodomain Binds H3K27triMe
and Pc-box
Cbx6 PRC1 Chromodomain Binds H3K27triMe
and Pc-box
Cbx7 PRC1 Chromodomain Binds H3K27triMe
and Pc-box
Cbx8 (Pc3) PRC1 Chromodomain Binds H3K27triMe
and Pc-box
Posterior sex combs (Psc) and Bmi1 (Pcgf4) PRC1 RING finger Enhances ubiquitination
Suppressor of zeste 2 Mel18 (Pcgf2, Rnf110) PRC1 RING finger Compacts nucleosomes
(Su(z)2) Pcgf1 (Nspc1) BCOR RING finger
Polyhomeotic proximal (Ph-p) Phc1 (Edr, Mph1, Rae-28) PRC1 SAM Spreading?
and distal (Ph-d) Phc2 (Edr2, Mphj2, p36) PRC1 SAM Spreading?
Phc3 (Edr3, Hph3) PRC1 SAM Spreading?
Sex combs extra (Sce/dRing) Ring1 (Ring1A) PRC1/BCOR RING finger E3 ligase
Rnf2 (Ring1B, dinG) PRC1/BCOR RING finger E3 ligase
Pleiohomeotic (Pho) YY1 (NF-E1) PhoRC Zn fingers Recruitment?
dSfmbt mSfmbt (Smr) PhoRC Zn finger, MBT, Binds methylated histones
and SAM
Calypso Bap1 PR-DUB UCH Deubiquitinates H2A
Additional sex combs (Asx) Asxl1 PR-DUB Enhances Calypso activity
Bcor BCOR Ankyrin repeat Targeting H2A ubiquitination?




dRYBP Rybp (DEDAF, YEAF1) BCOR Zn finger Protein–protein interaction





Protein expression was performed as described previ-
ously (Phelan et al. 1999). Briefly, Sf9 cells in the expo-
nential growth phase were infected with baculovirus for
the desired proteins, and cells were harvested 40 h after
infection. Nuclear extracts were prepared as described
(Abmayr et al. 2001), and protein was bound to an M2
affinity resin (Sigma), washed with BC buffer (20
mM HEPES at pH 8.0, 0.2 mM EDTA, 20% glycerol, 0.2
mM PMSF, 0.5 mM DTT), with KCl concentrations up to
2 M, and eluted with 0.4 mg/mL Flag peptide.
Protein–Protein Interaction Assays 
Sf9 cells at a density of 5 x 105/mL were coinfected with
baculovirus for the candidate interacting proteins. Cells
were harvested after 40 h and washed with PBS, and cell
extracts were prepared by freezing/thawing three times in
the presence of protease inhibitors. Extracts were incubated
with M2 beads, washed with BC buffer with KCl concen-
trations up to 2 M, and eluted with 0.4 mg/mL Flag peptide.
Proteins were separated by SDS-PAGE and detected either
by Western blot or Colloidal Blue staining (Invitrogen).
Generation of Nucleosomal Arrays
The ClaI/Asp118 fragment of pG5E4 containing 10 5S
nucleosome positioning sequences was purified using stan-
dard molecular biology techniques. Purified G5E4 frag-
ment was end-labeled using Klenow and [α-32P]dATP.
Core nucleosomes were prepared from HeLa nuclei and
assembled into nucleosomal arrays using the salt gradient
dialysis method as previously described (Sif et al. 2001). 
Restriction Enzyme Accessibility Assay
The restriction enzyme accessibility assay was performed
essentially as described (Francis et al. 2001). Briefly, 1.5
nM nucleosomes was incubated with PcG proteins at the in-
dicated concentration for 30 min at 30°C. Afterward,
hSWI/SNF was added at concentrations determined not to
be rate-limiting, in the presence of 8 units of HhaI (New
England BioLabs) in 20 µL of reaction buffer containing
12 mM HEPES (pH 7.9), 0.2 nM EDTA, 1.5 mM MgCl
2, 
2.4
µg of BSA, 5% glycerol, 2 mM ATP, and 1 mM DTT. After
an additional 1 h at 30°C, the 20-µL reactions were
quenched by the addition of 10 µL of stop buffer: 10 mM
Tris (pH 7.7), 35 mM EDTA, 1% SDS, 0.1 mg/mL bromo-
phenol blue, and 1.5 mg/mL Proteinase K. Stopped reac-
tions were incubated for 45 min at 55°C, then resolved on
a 1% agarose gel before exposure to a phospho-imaging
screen and quantification using a Typhoon PhosphorImager
and ImageQuant software (GE Healthcare).
Evolutionary Analysis
The UniProt database was queried for proteins contain-
ing either chromodomains or RING domains. These lists
of proteins were further filtered by removing proteins that
did not contain a C-box in the chromodomain list or did
not contain the extra region of homology in the RING pro-
tein set. The proteins in these lists were classified as active
or inactive based on predicted overall charge, with +10.2
being the cutoff point, with proteins more positively
charged being classified as active. The cladogram was
generated by aligning the 18S rRNA sequences for each
of the listed organisms, and the cladogram was drawn
using the neighbor-joining method using NJplot.
RESULTS
Chromatin Compaction Is Conserved
in the Mouse PRC1 Complex
The domains responsible for chromatin compaction by
Drosophila PRC1 were shown by solution studies and by
electron microscopy to reside in the carboxy-terminal two-
thirds of the Psc protein (Francis et al. 2004; King et al.
2005). Function is dispersed in a large region of the pro-
tein, and there is a good correlation between how mutations
in Psc affect the in vivo phenotype and how those muta-
tions affect compaction by Psc in vitro. Bmi1, one of the
mouse homologs of Psc, is structurally quite different from
Psc. Although Bmi1 and Psc share a conserved RING fin-
ger and HTH domain, Bmi1 lacks the extended carboxy-
terminal region of Psc that is required for both in vitro and
in vivo function. Thus, we were interested in whether Bmi1
or another mouse PRC1 protein was capable of functioning
in isolation in vitro in a manner similar to Psc.
We expressed and purified individual components of
mouse Polycomb core complex (mPCC) and tested them
for the ability to inhibit remodeling in a solution protocol
based on restriction enzyme accessibility. Restriction en-
zyme cleavage is inhibited when the target DNA is organ-
ized into a nucleosome. ATP-dependent remodeling
proteins modify the nucleosomal structure in ways that
allow accessibility and cleavage, but in the presence of
PRC1, this activity is blocked. We measure the ability of
a PRC1 preparation to function by titrating it into a re-
modeling reaction and measuring the extent to which re-
striction enzyme access is inhibited. This function has
generally correlated well with the ability to compact chro-
matin, as studied using electron microscopy (Francis et al.
2004). Using this protocol, a reconstituted complex con-
taining proteins Bmi1, M33/Cbx2, and Ring1a showed ac-
tivity similar to that seen with Drosophila Psc (Fig. 1).
We tested individual mouse PcG proteins to determine
whether any single protein is able to inhibit remodeling.
Bmi1 does not significantly inhibit remodeling at the con-
centrations of protein tested (Fig. 1), consistent with the
fact that it does not contain a region homologous to the
compaction domain defined in Psc. Next, we tested the
other components of the minimal core complex for repres-
sion activity. Similar to Bmi1, Ring1a does not show any
appreciable activity on its own. However, M33/Cbx2 in-
hibits remodeling to an extent similar to the mouse core
complex and Psc. This is surprising because we had pre-
viously observed little in vitro activity of the Drosophila
homolog of M33/Cbx2, Pc.
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To further investigate the observed activity of M33/
Cbx2, we performed a structure/function analysis to deter-
mine what domain(s) of M33/Cbx2 are required for func-
tional activity. Deletion of either the chromodomain or the
C-box of M33/Cbx2 does not significantly decrease its ac-
tivity (Fig. 1B,C). The chromodomain of Cbx/Pc proteins
is involved in targeting to chromatin (Fischle et al. 2003),
and the C-box is required for repression activity in trans-
fection assays (Schoorlemmer et al. 1997) as well as form-
ing interactions with other PRC1 components (Satijn et al.
1997). Targeting is not anticipated to be necessary in vitro
because association with the template is driven by mass ac-
tion; thus, the lack of requirement for the chromodomain
was not surprising. The lack of requirement for the C-box
in vitro indicates that this domain might function primarily
by directing interactions with other PcG proteins and thus
may not be necessary for function of the isolated protein. 
We next decided to create a series of truncation mutants
to map where the repression activity was located. Progres-
sive deletion into the core of M33/Cbx2 from either end
of the protein results in increasing loss of in vitro activity
(Fig. 1C,D). This observation is reminiscent of what was
seen for Psc: Functional activity spreads throughout the
extended carboxyl terminus of Psc, with further truncation
of the carboxyl terminus correlating with loss of both in
vitro and in vivo activity. This is consistent with the idea
that there is no well-defined repression domain but, rather,
that repression activity is spread throughout the carboxyl
terminus of the protein.
Through examination of the M33/Cbx2 sequence, we ob-
served what appears to be an overrepresentation of two
basic amino acids, lysine and arginine. This abundance of
basic amino acids is similar to what is found in the carboxyl
terminus of Psc. We hypothesized that one of the repressive
activities of the PcG proteins is mediated by a region of a
PRC1 subunit with a high overall positive charge. We imag-
ined that a localized region of high positive charge could
potentially interact with nucleosomal DNA and mediate the
compaction of chromatin, and block transcriptional activa-
tors from having access to their cognate sequences.
If this hypothesis were true, we would expect there to
be a correlation between the charge of a given M33/Cbx2
mutant and resulting in vitro activity. In fact, if we plot the
charge of a given M33/Cbx2 mutant versus the concen-
tration required for 50% inhibition of remodeling (IC50),
we see a significant correlation (Fig. 2). This result is con-
sistent with the idea that charge is an important determi-
nant of PRC1 activity. 
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Figure 1. Repressive activity of PcG protein M33. PcG proteins were titrated into a reaction containing nucleosomal arrays and incu-
bated before addition of hSWI/SNF and HhaI. Remodeling is measured by quantifying the ratio of DNA cut by HhaI to uncut DNA.
The percent inhibition of remodeling is calculated by using the following equation:
(% uncut with hSWI/SNF and PRC1 or PCC – % uncut with hSWI/SNF)
_________________________________________________________________________________________________ x 100.
(% uncut without hSWI/SNF – % uncut with hSWI/SNF)
(A) The ability of M33 to inhibit remodeling is similar to Psc and mPCC. (B) Activity of M33 domain deletions. (C) Activity of M33
carboxy-terminal truncations. (D) Activity of M33 amino-terminal truncations.
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Evolutionary Divergence of PRC1 Function
Interestingly, the above analysis suggests that a different
subunit of mouse core PRC1 has coopted the activity of
Psc from the Drosophila core complex. Bmi1, the mouse
homolog of Psc, is inactive in our in vitro assay. This is in
contrast to M33/Cbx2, a mouse homolog of Pc, which is
active. These observations could be explained in an evo-
lutionary context by either coevolution of this particular
PcG activity or by gain of this activity by one subunit fol-
lowed by loss in another. Regardless of what actually oc-
curred evolutionarily, both of these models suggest that
organisms evolutionarily close to Drosophila are expected
to have Psc homologs with high overall positive charge.
Likewise, we expect organisms evolutionarily closer to
mouse to have Pc homologs with high overall positive
charge. To test this hypothesis, we examined divergent ho-
mologs of Psc and Pc in multiple species and analyzed the
charge characteristics of each protein.
To accomplish this in an unbiased manner, we used a
computational approach to “call” PcG proteins and clas-
sify them as active or inactive based on charge. To call Pc
(or M33) homologs, we queried the SWISS-PROT data-
base for proteins containing a chromodomain and a C-box
motif, the hallmarks of this class of PcG protein. To find
Psc homologs, the database was queried using the con-
served RING domain plus the extended homology domain
of Psc. This method yielded 44 M33/Cbx2 homologs and
59 Psc homologs. Although we cannot exclude the possi-
bility that putative PcG proteins were missed, the proteins
that were called should be representative and are likely to
contain the majority of homologs in the database. Notably,
many proteins that were called have GO classifications of
PcG proteins, and one protein, Caenorhabditis elegans
Mig-32, has recently been shown to be a functional Psc
homolog in the worm (Karakuzu et al. 2009). 
To classify the proteins as either active or inactive, we
used the predicted charge at pH 7 and set a threshold of
+10.2 for candidate homologs to be categorized as inac-
tive. This cutoff was defined based on results with tested
PcG proteins as described above. Even though we expect
the activity to fall along a range, dependent on the charge
level, this binary system makes testing the predictions
simpler. Using this criterion, we find that 32 of 44
M33/Cbx2 homologs are predicted to be “active” in our
assay. In contrast, 55 of 59 Psc homologs are predicted to
be “inactive.” 
To further understand these results in the context of evo-
lution, we generated a cladogram using an alignment of
the 18S rRNAs from each of the species in which we
found putative PcG proteins (Fig. 3). There is a clear di-
chotomy: Organisms more closely related to Drosophila
have Psc homologs that are predicted to be active, whereas
the organisms more closely related to mouse have Pc
(M33/ Cbx2) homologs that are predicted to be active. Of
note is that despite the high number of Psc homologs in
mammals, none was classified as active. These results
support the hypothesis that during evolution this particular
activity of PRC1 was “swapped” among different sub-
units.
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Figure 2. Correlation of M33 repression ac-
tivity and charge. (A) Table lists charge and
observed activity of M33/Cbx2 mutants.
“Size” column is in kilodaltons. Charge was
estimated at pH 7.0 using lasergene software.
(Asterisks) IC
50
was inferred by extrapolating
curve fits. (B) Plot of predicted charge at pH
7 and observed IC
50 
for inhibition of remod-
eling.
Figure 3. Predicted repression activity of evolutionary PcG homologs. (A) Cladogram of species generated by alignment of 18S ribosomal
RNA sequences. (B) Number of predicted PcG proteins from each species and number of proteins over the charge threshold of +10.2.
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Interaction of the Zeste Protein
with PRC1 in Drosophila
The targeting of Polycomb-group proteins and the ac-
tivity at loci distant from the nucleation sites are funda-
mental issues in the mechanism of PcG silencing. Simple
models of sequential action by PRC2, which methylates
K27 on histone H3, and PRC1, which binds the K27 mark
via the Pc chromodomain, are not sufficient to explain
PRC1 recruitment. The affinity of the chromodomain of
Pc for trimethylated lysine 27 on histone H3 is low (Fis-
chle et al. 2003), and certain Pc homologs do not display
a strong preference for K27 methylation over K9 methyl-
ation (Bernstein et al. 2006). Histone marks might confer
an extra level of stability to the binding of PRC1, which
is important, but histone methylation is unlikely to be the
sole mechanism of targeting.
Studies using Drosophila have identified a multitude of
DNA-binding proteins that recognize PREs and are pro-
posed to recruit PcG complexes via direct interaction. One
such factor, Zeste (Fig. 4A), was identified as an integral
component of the PRC1 complex as isolated from
Drosophila embryos (Saurin et al. 2001), which suggested
a mechanism for directly targeting the complex to chro-
matin. Interestingly, Zeste, which is a transcriptional acti-
vator for the Ubx gene (Biggin et al. 1988), has been
classified as a Trithorax-group protein and shown to inter-
act physically with several Brahma-associated factors
(BAFs) in the Brahma complex (Kal et al. 2000). Such du-
alism is confirmed by the fact that Zeste is required for the
maintenance of both active (Déjardin and Cavalli 2004)
and repressed (Hur et al. 2002) states of transcription, in
both cases, an activity that depends on TrxG/PcG function.
To characterize how the Zeste protein interacts with
PRC1, we used a reconstitution approach to define the
binding interaction and to determine whether we could
measure a functional outcome of that interaction. We coin-
fected Sf9 cells with baculovirus for the four core PRC1
factors, or these factors plus Zeste, and purified the PCC
and PCCZ complexes, respectively, through the Flag tag
on the subunit Ph. We were able to generate complexes
with stoichiometric levels of Zeste protein, indicating that
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Figure 4. The interaction of Zeste with Polyhomeotic. (A) The domain structure of the Zeste protein. (DBD) DNA-binding domain,
(AD) activation domain, (QA) glutamine/alanine-rich domain, (Pro) proline-rich domain, (Leu-Zip) leucine zipper. (B) Purification
of recombinant PCC and PCC-Zeste from Baculovirus-infected Sf9 cells. (Arrow) Zeste, (asterisk)  contaminating band. (C) Western
blot for Zeste, for input and protein purified through the Flag tag on the indicated protein, coinfected with Zeste. PCC∆Ph is a coin-
fection with FLAG-Psc, dRING, Pc, and Zeste. (D) FLAG-PH was coinfected with the indicated mutants of Zeste and purified through
the Flag tag. Western blot for input and purified protein for Zeste. (Z1) K425M point mutant, (Z∆CT) carboxy-terminal truncation
that eliminates the proline-rich and leucine-zipper domains. (E) Full-length HA-tagged Zeste was coinfected with a Flag-tagged version
of the indicated truncation mutants, and protein that was purified through the Flag tag was detected by Colloidal Blue staining. (Arrow)
Full-length Zeste, (asterisk) nonspecific protein, (– lane [above, left]) infection with full-length Zeste alone. (F) Colloidal Blue staining
of protein purified through the Flag tag of PH, in the combinations indicated. Zeste is the thicker band just above the nonspecific
protein found on all purifications.
95
Zeste associates strongly with the core PRC1 (Fig. 4B). We
then asked whether this interaction is mediated by a direct
physical contact with one of the core factors. To this end,
we coinfected Sf9 cells with baculovirus for Zeste and a
Flag-tagged version of each of the PCC proteins. We then
purified the Flag-tagged protein and identified Zeste in the
eluates by western blot. Ph is both sufficient and necessary
for the association of Zeste with PCC, because Ph alone
bound to Zeste and a partial PCC complex lacking Ph 
(PCC∆Ph) was unable to interact with Zeste (Fig. 4C).
Having defined Ph as the interacting protein, we used the
same strategy described above to characterize the domains
required for interaction between Ph and Zeste. We made
several deletion mutants of Zeste for use in interaction stud-
ies. Mutants lacking the activation domain, proline-rich do-
main, DNA-binding domain, or a K425M mutant (the z1
mutant, which displays a neomorphic phenotype in flies)
were all able to interact with FLAG-Ph (Fig. 4D). In con-
trast, mutants that lack the carboxyl terminus (proline-rich
and leucine-zipper domains) or that lack the leucine zipper
only, do not copurify with FLAG-Ph.
The leucine-zipper domain of Zeste has previously been
found to be involved in a physical interaction with Moira,
a subunit of the TrxG Brahma complex (Kal et al. 2000).
Additionally, it has been implicated in aggregation of the
Zeste protein, which has been suggested to have a role in
the in vivo function of Zeste (Chen and Pirrotta 1993).
Consistent with this observation, a mutant lacking the
leucine zipper was shown to be deficient in self-association
(Fig. 4E). We tested self-association by coinfecting Sf9 cells
with full-length HA-tagged Zeste and a Flag-tagged ver-
sion of a Zeste mutant that lacked one of either the activa-
tion, the proline-rich, or the leucine-zipper domains.
Protein purified over an M2 Flag affinity column was sep-
arated by PAGE and stained with Colloidal Blue. The
leucine-zipper mutant is unable to recruit full-length Zeste,
indicating that this domain is necessary for self-interaction.
We next were interested in testing whether a known in-
teraction module in Ph, the SAM domain, mediates the in-
teraction with Zeste. We coinfected Sf9 cells with
FLAG-Ph or FLAG-Ph∆SAM and Zeste. As a positive
control, we used Sex Comb on the Midleg (Scm), a PcG
protein known to interact with the SAM domain of Ph. As
expected, we could see a SAM-dependent interaction be-
tween Ph and Scm (Fig. 4F). Furthermore, the Ph∆SAM
mutant had a much lower affinity for Zeste, suggesting
that the SAM domain is a common docking site for both
Scm and Zeste. Binding to Ph is possibly done using dif-
ferent surfaces of the SAM domain, because both Scm and
Zeste can copurify with Ph simultaneously.
We wished to determine whether the interaction be-
tween Ph and Zeste has a measurable impact on activity
of either Ph alone or the core PRC1 complex. To perform
these studies, we first determined the function of Ph alone.
As discussed above, the inhibitory activity of PRC1 on
chromatin appears to be due to the high positive charge of
the complex, a characteristic that is unique to PRC1
among the known fly PcG complexes (Fig. 5A). Interest-
ingly, a different complex that includes Psc, the dRAF
complex (Lagarou et al. 2008), is not known to have a di-
rect impact on chromatin remodeling activity and bears
an overall charge of –17.3. This suggests that other factors
in PRC1 contribute to the overall charge and, therefore,
activity. Ph, although not as positively charged as Psc,
bears a net charge above the threshold that was used for
calling a PcG protein as potentially active in the inhibition
of remodeling. Likewise, a Ph homolog in mouse, RAE-
28, also has an intermediate positive charge. 
To determine whether the predicted charge of these pro-
teins was indicative of biochemical activity, we measured
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Figure 5. Functional analysis of Polyhomeotic and Zeste. (A)
Charge of the PRC1 core complex proteins from Drosophila and
mouse and of other Drosophila PcG complexes and Zeste. (B)
Swi/Snf remodeling inhibition by dPCC, Psc, and Ph. (C) Inter-
action of wild-type and mutant Zeste with Ph in Swi/Snf.
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the ability of purified recombinant PCC, Psc, and Ph to
inhibit remodeling with the REA assay. As expected, PCC
has the strongest inhibitory activity, closely followed by
Psc (Fig. 5B). Ph displayed measurable inhibitory activity,
albeit only at higher concentrations than PCC or Psc.
Zeste has previously been shown to have an impact on
the activity of PCC (Mulholland et al. 2003). Given the
physical interaction between Zeste and Ph (Fig. 4), Zeste
might directly enhance the activity of Ph. To test this hy-
pothesis, we again used the REA assay. By preincubation
of the nucleosomal arrays with either Ph alone or Ph plus
wild-type or mutant versions of Zeste, we could determine
whether Zeste enhances the activity of Ph (Fig. 5C). The
inclusion of Zeste in the preincubation has a measurable,
but modest, effect on the activity of Ph, more prominent
at lower concentrations. Removal of either the DNA-bind-
ing domain (Z∆DBD) or the leucine-zipper domain
(Z∆LZ) abrogated the stimulatory effect of Zeste. These
results suggest that the interaction of Zeste with Ph stim-
ulates the inhibitory activity of Ph, dependent on both the
DNA-binding domain and the leucine-zipper domain of
Zeste. This dependence might be due to either the reduced
physical interaction of the Z∆LZ mutant with Ph or to the
inability of this mutant to oligomerize. The effect of Zeste
on Ph is unlikely to be related to charge because Zeste has
a net negative charge.
DISCUSSION
We have examined the biochemically active regions of
two key components of PRC1 and have generated the hy-
pothesis that the high net positive charge of these regions
is important for the ability of PRC1 to compact chromatin.
Surprisingly, the region enriched for basic amino acids,
which was originally identified in the Drosophila Psc pro-
tein, appears to have swapped location to the mouse Pc
homolog at some time during the evolutionary process.
Although these regions do not show significant sequence
alignment when the relevant PcG proteins are compared,
it does appear that the overall amino acid content has been
maintained. Every organism we examined contains at least
one component of PRC1 that has the characteristic high
positive charge. An important test of the hypothesis that
this charge distribution is central to compaction will in-
volve testing the extent of compaction produced by the
various PRC1 proteins from different species.
The role of PRC1 in compacting chromatin in vitro has
been well established by our previous work, and the ability
of Drosophila Psc to compact chromatin in vitro has been
correlated with its ability to repress homeotic genes in
vivo (King et al. 2005). More recent studies support the
hypothesis that compaction is a key function of the PcG
system and that PRC1 is a central player in this activity. A
study of nucleosome turnover revealed slower rates of
turnover on genes repressed by the PcG system than on
genes bound by Trithorax-group protein, consistent with
a more inaccessible state (Deal et al. 2010). A study that
looked at compaction at the cytological level showed that
the HOX clusters in mouse are compacted when repressed
and that compaction is dependent on PRC1, but not on the
ubiquitylation function of PRC1 (Eskeland et al. 2010).
This result separates the compaction and enzymatic func-
tions of PRC1 and suggests that compaction has the pri-
mary role in the repression of HOX. The compaction
observed in these studies in mice, measured cytologically,
might be caused by the same PRC1 function that represses
remodeling and creates compacted structures visible by
electron microscopy. It is important to recognize that these
two events have not yet been equated mechanistically.
The swapping of the compaction domain between Psc
and Pc homologs has important ramifications for the in-
terplay between histone H2A ubiquitylation and com-
paction. The ubiquitylation activity requires a Psc homolog
and a RING homolog. There are at least two distinct PRC1
family complexes that contain both Psc and RING ho-
mologs in Drosophila and mammals. The originally de-
fined PRC1 complex contains Psc, Pc, Pc, and RING
homologs, whereas the dRAF complex (Drosophila) and
BCOR complex (mammals) contain Psc and RING ho-
mologs but are not known to contain Pc homologs. Inter-
estingly, the inclusion of the highly positively charged Psc
in the dRAF complex is accompanied by the presence of
the highly negatively charged Mtor and Ulp1, with the
whole complex having a net charge of –17.3. These latter
complexes in the PRC1 family are proficient at ubiquity-
lation and have been proposed to be the central ubiquity-
lating complexes in Drosophila and mammals. The swap
of the compaction domain between Psc and Pc means that
in mammals, the compaction activity is found in only one
subset of the PRC1 complexes, whereas in Drosophila, this
domain is found in both PRC1 and dRAF. In mammals and
in most organisms listed in our evolutionary comparison,
there is the potential to separate these two functions be-
tween complexes. One can imagine that inclusion or omis-
sion of certain PcG functions could fine-tune the level of
either compaction or ubiquitylation at the various genes
regulated by the PRC1 family of complexes.
We have also mapped the domains involved in the as-
sociation of the Zeste protein with PRC1 in Drosophila
but were unable to uncover a clear functional role for that
interaction. The Zeste protein is of significant interest in
the biology of PRC1 because it binds stoichiometrically
to the complex, both during reconstitution and when
PRC1 is isolated from embryos, and it has a rich history
of involvement in gene regulation, as determined by ge-
netic studies (Pirrotta 1991). It therefore seems a strong
candidate to have an important role in regulating PRC1
function. The types of role(s) that it might have are per-
plexing, because the genetic studies implicate it in both
activation and repression, and it does not display classic
PcG phenotypes and, in fact, displays some of the oppos-
ing Trithorax-group phenotypes.
Zeste interacts with Ph, a PRC1 subunit that is involved
in bridging interactions either involving self-association or
association with proteins such as Scm. Zeste is also able to
self-associate. It is possible, then, that Zeste might modulate
higher-order interactions between PcG complexes and tar-
gets. We tested whether Zeste might be involved in regulat-
ing compaction on arrays, possibly stimulated by changes
in association, but did not observe any striking effects when
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Zeste was either combined with Ph alone or mixed with a
full PRC1 reconstituted complex. In both instances, Zeste
increased the ability to repress remodeling, but the effects
were of modest magnitude. Perhaps a simple possibility ex-
plains the interaction of Zeste with PRC1: Zeste has the
ability to bind DNA with sequence specificity, and it might
solely target the complex without affecting activity. Its in-
tricate genetic functions, the involvement in trans-sensing
and -acting phenomena like transvection, and its ability to
interact with the Brahma complex, a Trithorax-group com-
plex, indicate, on the other hand, that something more com-
plex might be involved.
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